<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Vistalytics - iFile Suite version 6.233 -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://www.mentorcapital.com/20170331"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
	<link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_InterestExpense4' xlink:label='fil_InterestExpense4'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestExpense4' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest expense;</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestExpense4' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount of the cost of borrowed funds accounted for as interest expense.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InterestExpense4' xlink:to='lab_fil_InterestExpense4'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_InterestExpense2' xlink:label='fil_InterestExpense2'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestExpense2' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest expense,</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestExpense2' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount of the cost of borrowed funds accounted for as interest expense.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InterestExpense2' xlink:to='lab_fil_InterestExpense2'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_TrashManagementAbstract' xlink:label='fil_TrashManagementAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TrashManagementAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Trash Management</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TrashManagementAbstract' xlink:to='lab_fil_TrashManagementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_OffsetByShareholderAdvance' xlink:label='fil_OffsetByShareholderAdvance'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_OffsetByShareholderAdvance' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Offset by shareholder advance</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_OffsetByShareholderAdvance' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Offset by shareholder advance</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_OffsetByShareholderAdvance' xlink:to='lab_fil_OffsetByShareholderAdvance'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_UnamortizedLoanServiceFeeBalance1' xlink:label='fil_UnamortizedLoanServiceFeeBalance1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_UnamortizedLoanServiceFeeBalance1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Unamortized loan service fee balance</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_UnamortizedLoanServiceFeeBalance1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Unamortized loan service fee balance</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_UnamortizedLoanServiceFeeBalance1' xlink:to='lab_fil_UnamortizedLoanServiceFeeBalance1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_LeaseCommitmentsDetailsAbstract' xlink:label='fil_LeaseCommitmentsDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LeaseCommitmentsDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Lease Commitments Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LeaseCommitmentsDetailsAbstract' xlink:to='lab_fil_LeaseCommitmentsDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PreferredStockAuthorizedShares' xlink:label='fil_PreferredStockAuthorizedShares'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PreferredStockAuthorizedShares' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred Stock authorized shares</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PreferredStockAuthorizedShares' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity&apos;s charter and bylaws.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PreferredStockAuthorizedShares' xlink:to='lab_fil_PreferredStockAuthorizedShares'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_TransferringRedemptionFeeToTheFormerHolders' xlink:label='fil_TransferringRedemptionFeeToTheFormerHolders'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TransferringRedemptionFeeToTheFormerHolders' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Transferring redemption fee to the former holders</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TransferringRedemptionFeeToTheFormerHolders' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Transferring redemption fee to the former holders</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TransferringRedemptionFeeToTheFormerHolders' xlink:to='lab_fil_TransferringRedemptionFeeToTheFormerHolders'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_SummarizesEFGAndHWarrantsAbstract' xlink:label='fil_SummarizesEFGAndHWarrantsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_SummarizesEFGAndHWarrantsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Summarizes E, F, G and H Warrants</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_SummarizesEFGAndHWarrantsAbstract' xlink:to='lab_fil_SummarizesEFGAndHWarrantsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_CompanyIssuedSeriesHWithParValue7Warrants' xlink:label='fil_CompanyIssuedSeriesHWithParValue7Warrants'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyIssuedSeriesHWithParValue7Warrants' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company issued Series H with par value $7 Warrants</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyIssuedSeriesHWithParValue7Warrants' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company issued Series H with par value $7 Warrants</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanyIssuedSeriesHWithParValue7Warrants' xlink:to='lab_fil_CompanyIssuedSeriesHWithParValue7Warrants'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_Issuances' xlink:label='fil_Issuances'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Issuances' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issuances</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Issuances' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Issuances</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Issuances' xlink:to='lab_fil_Issuances'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_FairValueMeasurementsUsingSignificantUnobservableInputsLevel3EquityFundingAgreementsMember' xlink:label='fil_FairValueMeasurementsUsingSignificantUnobservableInputsLevel3EquityFundingAgreementsMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_FairValueMeasurementsUsingSignificantUnobservableInputsLevel3EquityFundingAgreementsMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair Value Measurements Using Significant Unobservable Inputs (Level 3) Equity Funding Agreements</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_FairValueMeasurementsUsingSignificantUnobservableInputsLevel3EquityFundingAgreementsMember' xlink:to='lab_fil_FairValueMeasurementsUsingSignificantUnobservableInputsLevel3EquityFundingAgreementsMember'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ContractualInterestInLegalRecoveryDetailsAbstract' xlink:label='fil_ContractualInterestInLegalRecoveryDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ContractualInterestInLegalRecoveryDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Contractual interest in legal recovery Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ContractualInterestInLegalRecoveryDetailsAbstract' xlink:to='lab_fil_ContractualInterestInLegalRecoveryDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ReservePendingCollectionEfforts1' xlink:label='fil_ReservePendingCollectionEfforts1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ReservePendingCollectionEfforts1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Reserve pending collection efforts</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ReservePendingCollectionEfforts1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Reserve pending collection efforts</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ReservePendingCollectionEfforts1' xlink:to='lab_fil_ReservePendingCollectionEfforts1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PaymentOfTheOriginalPurchasePricePerShare' xlink:label='fil_PaymentOfTheOriginalPurchasePricePerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PaymentOfTheOriginalPurchasePricePerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Payment of the original purchase price per share</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PaymentOfTheOriginalPurchasePricePerShare' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Payment of the original purchase price per share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PaymentOfTheOriginalPurchasePricePerShare' xlink:to='lab_fil_PaymentOfTheOriginalPurchasePricePerShare'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_InterestPayments' xlink:label='fil_InterestPayments'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestPayments' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest payments</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestPayments' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Interest payments</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InterestPayments' xlink:to='lab_fil_InterestPayments'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ConvertibleNoteReceivableFromElectrumCapitalPartnersLlcIsRecordedAtTheLoanAmount' xlink:label='fil_ConvertibleNoteReceivableFromElectrumCapitalPartnersLlcIsRecordedAtTheLoanAmount'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertibleNoteReceivableFromElectrumCapitalPartnersLlcIsRecordedAtTheLoanAmount' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Convertible note receivable from Electrum Capital Partners, LLC is recorded at the loan amount</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertibleNoteReceivableFromElectrumCapitalPartnersLlcIsRecordedAtTheLoanAmount' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Convertible note receivable from Electrum Capital Partners, LLC is recorded at the loan amount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConvertibleNoteReceivableFromElectrumCapitalPartnersLlcIsRecordedAtTheLoanAmount' xlink:to='lab_fil_ConvertibleNoteReceivableFromElectrumCapitalPartnersLlcIsRecordedAtTheLoanAmount'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_MentorHasAInterestInWasteConsolidatorsInc' xlink:label='fil_MentorHasAInterestInWasteConsolidatorsInc'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_MentorHasAInterestInWasteConsolidatorsInc' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Mentor has a interest in Waste Consolidators, Inc</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_MentorHasAInterestInWasteConsolidatorsInc' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Mentor has a interest in Waste Consolidators, Inc</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_MentorHasAInterestInWasteConsolidatorsInc' xlink:to='lab_fil_MentorHasAInterestInWasteConsolidatorsInc'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_FairValueMeasuresAndDisclosuresAbstract' xlink:label='fil_FairValueMeasuresAndDisclosuresAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_FairValueMeasuresAndDisclosuresAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Hierarchy of Assets (Tables):</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_FairValueMeasuresAndDisclosuresAbstract' xlink:to='lab_fil_FairValueMeasuresAndDisclosuresAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock' xlink:label='us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Maturities of Long-term Debt</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ContractualInterestInLegalRecoveryTextBlock' xlink:label='fil_ContractualInterestInLegalRecoveryTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ContractualInterestInLegalRecoveryTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Contractual interest in legal recovery {2}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ContractualInterestInLegalRecoveryTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Contractual interest in legal recovery</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ContractualInterestInLegalRecoveryTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Contractual interest in legal recovery</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ContractualInterestInLegalRecoveryTextBlock' xlink:to='lab_fil_ContractualInterestInLegalRecoveryTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PropertyAndEquipmentAbstract' xlink:label='fil_PropertyAndEquipmentAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PropertyAndEquipmentAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property and equipment:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PropertyAndEquipmentAbstract' xlink:to='lab_fil_PropertyAndEquipmentAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract' xlink:label='us-gaap_OtherIncomeAndExpensesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherIncomeAndExpensesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other income and (expense)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherIncomeAndExpensesAbstract' xlink:to='lab_us-gaap_OtherIncomeAndExpensesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash' xlink:label='us-gaap_Cash'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Cash' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash and cash equivalents</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Cash' xlink:to='lab_us-gaap_Cash'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract' xlink:label='us-gaap_AssetsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AssetsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>ASSETS</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AssetsAbstract' xlink:to='lab_us-gaap_AssetsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol' xlink:label='dei_TradingSymbol'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_TradingSymbol' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Trading Symbol</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_TradingSymbol' xlink:to='lab_dei_TradingSymbol'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_IncreasingThePrincipalFaceAmountOfTheWorkingCapitalNoteBy100000To' xlink:label='fil_IncreasingThePrincipalFaceAmountOfTheWorkingCapitalNoteBy100000To'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncreasingThePrincipalFaceAmountOfTheWorkingCapitalNoteBy100000To' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Increasing the principal face amount of the working capital note by $100,000 to</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncreasingThePrincipalFaceAmountOfTheWorkingCapitalNoteBy100000To' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Increasing the principal face amount of the working capital note by $100,000 to</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IncreasingThePrincipalFaceAmountOfTheWorkingCapitalNoteBy100000To' xlink:to='lab_fil_IncreasingThePrincipalFaceAmountOfTheWorkingCapitalNoteBy100000To'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ShareholdersHoldSeriesBWarrants' xlink:label='fil_ShareholdersHoldSeriesBWarrants'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ShareholdersHoldSeriesBWarrants' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Shareholders hold Series B Warrants</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ShareholdersHoldSeriesBWarrants' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Shareholders hold Series B Warrants</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ShareholdersHoldSeriesBWarrants' xlink:to='lab_fil_ShareholdersHoldSeriesBWarrants'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_MarketableSecurities1Abstract' xlink:label='fil_MarketableSecurities1Abstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_MarketableSecurities1Abstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Marketable securities</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_MarketableSecurities1Abstract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Beginning balance</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_MarketableSecurities1Abstract' xlink:to='lab_fil_MarketableSecurities1Abstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_TotalAssets4' xlink:label='fil_TotalAssets4'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalAssets4' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total assets;</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalAssets4' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalAssets4' xlink:to='lab_fil_TotalAssets4'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PropertyAdditions2' xlink:label='fil_PropertyAdditions2'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PropertyAdditions2' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property additions.</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PropertyAdditions2' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Corporate unallocated and Eliminations - Property additions</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PropertyAdditions2' xlink:to='lab_fil_PropertyAdditions2'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_DepreciationAndAmortization1' xlink:label='fil_DepreciationAndAmortization1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DepreciationAndAmortization1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Depreciation and amortization {2}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_DepreciationAndAmortization1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Depreciation and amortization</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_DepreciationAndAmortization1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DepreciationAndAmortization1' xlink:to='lab_fil_DepreciationAndAmortization1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_IncomeBeforeTaxes' xlink:label='fil_IncomeBeforeTaxes'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncomeBeforeTaxes' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Income before taxes</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncomeBeforeTaxes' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Income before taxes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IncomeBeforeTaxes' xlink:to='lab_fil_IncomeBeforeTaxes'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_BookValueAtConfirmationBankruptcy' xlink:label='fil_BookValueAtConfirmationBankruptcy'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BookValueAtConfirmationBankruptcy' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Book value at confirmation bankruptcy</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_BookValueAtConfirmationBankruptcy' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Book value at confirmation bankruptcy</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BookValueAtConfirmationBankruptcy' xlink:to='lab_fil_BookValueAtConfirmationBankruptcy'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_InterestRatePerAnnumOnAutoLoansThroughHyundaiMotorFinance' xlink:label='fil_InterestRatePerAnnumOnAutoLoansThroughHyundaiMotorFinance'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestRatePerAnnumOnAutoLoansThroughHyundaiMotorFinance' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest rate per annum on auto loans through Hyundai Motor Finance</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestRatePerAnnumOnAutoLoansThroughHyundaiMotorFinance' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Interest rate per annum on auto loans through Hyundai Motor Finance</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InterestRatePerAnnumOnAutoLoansThroughHyundaiMotorFinance' xlink:to='lab_fil_InterestRatePerAnnumOnAutoLoansThroughHyundaiMotorFinance'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_CompanyAnnouncedThatItWasInitiatingTheRepurchaseOfApproximately' xlink:label='fil_CompanyAnnouncedThatItWasInitiatingTheRepurchaseOfApproximately'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyAnnouncedThatItWasInitiatingTheRepurchaseOfApproximately' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company announced that it was initiating the repurchase of approximately</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyAnnouncedThatItWasInitiatingTheRepurchaseOfApproximately' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company announced that it was initiating the repurchase of approximately</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanyAnnouncedThatItWasInitiatingTheRepurchaseOfApproximately' xlink:to='lab_fil_CompanyAnnouncedThatItWasInitiatingTheRepurchaseOfApproximately'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_WarrantsExercised' xlink:label='fil_WarrantsExercised'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsExercised' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrants Exercised</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsExercised' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Warrants Exercised</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantsExercised' xlink:to='lab_fil_WarrantsExercised'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_SeriesB1Member' xlink:label='fil_SeriesB1Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_SeriesB1Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Series B {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_SeriesB1Member' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Series B</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_SeriesB1Member' xlink:to='lab_fil_SeriesB1Member'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PurchasesIssuancesSalesAndSettlementsAbstract' xlink:label='fil_PurchasesIssuancesSalesAndSettlementsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PurchasesIssuancesSalesAndSettlementsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Purchases, issuances, sales, and settlements</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PurchasesIssuancesSalesAndSettlementsAbstract' xlink:to='lab_fil_PurchasesIssuancesSalesAndSettlementsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_GFarmaPurchasedRestrictedSharesOfTheCompanySCommonStockAnAggregatePurchasePrice' xlink:label='fil_GFarmaPurchasedRestrictedSharesOfTheCompanySCommonStockAnAggregatePurchasePrice'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_GFarmaPurchasedRestrictedSharesOfTheCompanySCommonStockAnAggregatePurchasePrice' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>G Farma purchased restricted shares of the Company&apos;s Common Stock an aggregate purchase price</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_GFarmaPurchasedRestrictedSharesOfTheCompanySCommonStockAnAggregatePurchasePrice' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>G Farma purchased restricted shares of the Company&apos;s Common Stock an aggregate purchase price</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_GFarmaPurchasedRestrictedSharesOfTheCompanySCommonStockAnAggregatePurchasePrice' xlink:to='lab_fil_GFarmaPurchasedRestrictedSharesOfTheCompanySCommonStockAnAggregatePurchasePrice'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MachineryAndEquipmentGross' xlink:label='us-gaap_MachineryAndEquipmentGross'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_MachineryAndEquipmentGross' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Machinery and vehicles</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_MachineryAndEquipmentGross' xlink:to='lab_us-gaap_MachineryAndEquipmentGross'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_DiscountAmortizationIncludedInInterestIncome' xlink:label='fil_DiscountAmortizationIncludedInInterestIncome'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DiscountAmortizationIncludedInInterestIncome' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Discount amortization included in interest income</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_DiscountAmortizationIncludedInInterestIncome' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Discount amortization included in interest income</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DiscountAmortizationIncludedInInterestIncome' xlink:to='lab_fil_DiscountAmortizationIncludedInInterestIncome'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_Total' xlink:label='fil_Total'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Total' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Total' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Total' xlink:to='lab_fil_Total'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PrepaidExpensesAndOtherCurrentAssets' xlink:label='fil_PrepaidExpensesAndOtherCurrentAssets'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PrepaidExpensesAndOtherCurrentAssets' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Prepaid expenses and other current assets {2}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PrepaidExpensesAndOtherCurrentAssets' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Prepaid expenses and other current assets</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PrepaidExpensesAndOtherCurrentAssets' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PrepaidExpensesAndOtherCurrentAssets' xlink:to='lab_fil_PrepaidExpensesAndOtherCurrentAssets'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_OtherPrepaidCosts' xlink:label='fil_OtherPrepaidCosts'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_OtherPrepaidCosts' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other prepaid costs</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_OtherPrepaidCosts' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Other prepaid costs</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_OtherPrepaidCosts' xlink:to='lab_fil_OtherPrepaidCosts'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_GoodwillRelatedToAcquisitionInterestRate' xlink:label='fil_GoodwillRelatedToAcquisitionInterestRate'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_GoodwillRelatedToAcquisitionInterestRate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Goodwill related to acquisition interest rate</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_GoodwillRelatedToAcquisitionInterestRate' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Goodwill related to acquisition interest rate</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_GoodwillRelatedToAcquisitionInterestRate' xlink:to='lab_fil_GoodwillRelatedToAcquisitionInterestRate'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_DebtAbstract' xlink:label='fil_DebtAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DebtAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note purchase agreement and consulting agreement with G FarmaLabs Limited {2}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_DebtAbstract' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Note purchase agreement and consulting agreement with G FarmaLabs Limited</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DebtAbstract' xlink:to='lab_fil_DebtAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ScheduleOfReceivableFromBhangChocolateCompanyTextBlock' xlink:label='fil_ScheduleOfReceivableFromBhangChocolateCompanyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ScheduleOfReceivableFromBhangChocolateCompanyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Receivable from Bhang Chocolate Company</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ScheduleOfReceivableFromBhangChocolateCompanyTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the textual narrative disclosure of Schedule of Receivable from Bhang Chocolate Company, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ScheduleOfReceivableFromBhangChocolateCompanyTextBlock' xlink:to='lab_fil_ScheduleOfReceivableFromBhangChocolateCompanyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk' xlink:label='us-gaap_ConcentrationRiskCreditRisk'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ConcentrationRiskCreditRisk' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Concentrations of cash</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ConcentrationRiskCreditRisk' xlink:to='lab_us-gaap_ConcentrationRiskCreditRisk'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_InvestmentsAndFairValueAbstract' xlink:label='fil_InvestmentsAndFairValueAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InvestmentsAndFairValueAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Investments and fair value</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InvestmentsAndFairValueAbstract' xlink:to='lab_fil_InvestmentsAndFairValueAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:label='us-gaap_CashAndCashEquivalentsAtCarryingValue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Beginning cash</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:role='http://www.xbrl.org/2003/role/periodStartLabel' xml:lang='en-US'>Beginning cash</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:role='http://www.xbrl.org/2003/role/periodEndLabel' xml:lang='en-US'>Ending cash</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:to='lab_us-gaap_CashAndCashEquivalentsAtCarryingValue'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireOtherReceivables' xlink:label='us-gaap_PaymentsToAcquireOtherReceivables'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PaymentsToAcquireOtherReceivables' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Receipt of investment in receivable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PaymentsToAcquireOtherReceivables' xlink:to='lab_us-gaap_PaymentsToAcquireOtherReceivables'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromPaymentsForTradingSecurities' xlink:label='us-gaap_ProceedsFromPaymentsForTradingSecurities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProceedsFromPaymentsForTradingSecurities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Purchase of investment securities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ProceedsFromPaymentsForTradingSecurities' xlink:to='lab_us-gaap_ProceedsFromPaymentsForTradingSecurities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TechnologyServicesCosts' xlink:label='us-gaap_TechnologyServicesCosts'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_TechnologyServicesCosts' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Webcast revenue</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_TechnologyServicesCosts' xlink:to='lab_us-gaap_TechnologyServicesCosts'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract' xlink:label='us-gaap_LiabilitiesNoncurrentAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesNoncurrentAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Long-term liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesNoncurrentAbstract' xlink:to='lab_us-gaap_LiabilitiesNoncurrentAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent' xlink:label='us-gaap_AccountsPayableCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccountsPayableCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounts payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccountsPayableCurrent' xlink:to='lab_us-gaap_AccountsPayableCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent' xlink:label='us-gaap_AccountsAndOtherReceivablesNetCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccountsAndOtherReceivablesNetCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Investment in account receivable, net of discount and current portion</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccountsAndOtherReceivablesNetCurrent' xlink:to='lab_us-gaap_AccountsAndOtherReceivablesNetCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' xlink:label='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accumulated depreciation and amortization</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' xlink:to='lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent' xlink:label='us-gaap_AssetsCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AssetsCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total current assets</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AssetsCurrent' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Total current assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AssetsCurrent' xlink:to='lab_us-gaap_AssetsCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent' xlink:label='us-gaap_PrepaidExpenseAndOtherAssetsCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Prepaid expenses and other current assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PrepaidExpenseAndOtherAssetsCurrent' xlink:to='lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat' xlink:label='dei_EntityPublicFloat'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityPublicFloat' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Public Float</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityPublicFloat' xlink:to='lab_dei_EntityPublicFloat'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_InterestExpense5' xlink:label='fil_InterestExpense5'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestExpense5' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest expense {2}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestExpense5' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Interest expense</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestExpense5' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount of the cost of borrowed funds accounted for as interest expense.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InterestExpense5' xlink:to='lab_fil_InterestExpense5'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ConsolidatedAbstract' xlink:label='fil_ConsolidatedAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConsolidatedAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Consolidated</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConsolidatedAbstract' xlink:to='lab_fil_ConsolidatedAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_InterestIncome2' xlink:label='fil_InterestIncome2'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestIncome2' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest income,</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestIncome2' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The aggregate interest and fee income generated by: (1) loans the Entity has positive intent and ability to hold for the foreseeable future, or until maturity or payoff, including commercial and consumer loans, whether domestic or foreign, which may consist of: (a) industrial and agricultural; (b) real estate; and (c) real estate construction loans; (d) trade financing; (e) lease financing; (f) home equity lines-of-credit; (g) automobile and other vehicle loans; and (h) credit card and other revolving-type loans and (2) loans and leases held-for-sale which may include mortgage loans, direct financing, and sales-type leases.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InterestIncome2' xlink:to='lab_fil_InterestIncome2'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_AccruedSalariesAndBenefits' xlink:label='fil_AccruedSalariesAndBenefits'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccruedSalariesAndBenefits' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrued salaries and benefits</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccruedSalariesAndBenefits' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AccruedSalariesAndBenefits' xlink:to='lab_fil_AccruedSalariesAndBenefits'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_CommercialCreditAgreementWithBondStreetServicingLlcDetailsAbstract' xlink:label='fil_CommercialCreditAgreementWithBondStreetServicingLlcDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommercialCreditAgreementWithBondStreetServicingLlcDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Commercial credit agreement with Bond Street Servicing, LLC Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CommercialCreditAgreementWithBondStreetServicingLlcDetailsAbstract' xlink:to='lab_fil_CommercialCreditAgreementWithBondStreetServicingLlcDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_SemiMonthlyPayments' xlink:label='fil_SemiMonthlyPayments'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_SemiMonthlyPayments' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Semi-monthly payments</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_SemiMonthlyPayments' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Semi-monthly payments.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_SemiMonthlyPayments' xlink:to='lab_fil_SemiMonthlyPayments'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_RentExpensePaidForOfficeSpaceInRamonaCalifornia' xlink:label='fil_RentExpensePaidForOfficeSpaceInRamonaCalifornia'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RentExpensePaidForOfficeSpaceInRamonaCalifornia' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Rent expense paid for office space in Ramona, California</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_RentExpensePaidForOfficeSpaceInRamonaCalifornia' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RentExpensePaidForOfficeSpaceInRamonaCalifornia' xlink:to='lab_fil_RentExpensePaidForOfficeSpaceInRamonaCalifornia'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_Issued1' xlink:label='fil_Issued1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Issued1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issued {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Issued1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Issued</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Issued1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Issued1' xlink:to='lab_fil_Issued1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_SeriesD' xlink:label='fil_SeriesD'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_SeriesD' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Series D</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_SeriesD' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Series D Common Stock Warrant Exercise Price</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_SeriesD' xlink:to='lab_fil_SeriesD'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_IncludedInEarningsOrChangesInNetAssets1' xlink:label='fil_IncludedInEarningsOrChangesInNetAssets1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncludedInEarningsOrChangesInNetAssets1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Included in earnings (or changes in net assets) {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncludedInEarningsOrChangesInNetAssets1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Included in earnings (or changes in net assets)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncludedInEarningsOrChangesInNetAssets1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Included in earnings (or changes in net assets)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IncludedInEarningsOrChangesInNetAssets1' xlink:to='lab_fil_IncludedInEarningsOrChangesInNetAssets1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_FairValueMeasurementsUsingUnadjustedQuotedMarketPricesLevel1EquitySecuritiesMember' xlink:label='fil_FairValueMeasurementsUsingUnadjustedQuotedMarketPricesLevel1EquitySecuritiesMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_FairValueMeasurementsUsingUnadjustedQuotedMarketPricesLevel1EquitySecuritiesMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair Value Measurements Using Unadjusted Quoted Market Prices (Level 1) Equity Securities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_FairValueMeasurementsUsingUnadjustedQuotedMarketPricesLevel1EquitySecuritiesMember' xlink:to='lab_fil_FairValueMeasurementsUsingUnadjustedQuotedMarketPricesLevel1EquitySecuritiesMember'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_RealEstateNote' xlink:label='fil_RealEstateNote'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RealEstateNote' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Real estate note</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_RealEstateNote' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Real estate note</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RealEstateNote' xlink:to='lab_fil_RealEstateNote'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_CompanyPurchasedTwoSecuredPromissoryNotesFromGFarma' xlink:label='fil_CompanyPurchasedTwoSecuredPromissoryNotesFromGFarma'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyPurchasedTwoSecuredPromissoryNotesFromGFarma' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company purchased two secured promissory notes from G Farma</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyPurchasedTwoSecuredPromissoryNotesFromGFarma' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company purchased two secured promissory notes from G Farma</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanyPurchasedTwoSecuredPromissoryNotesFromGFarma' xlink:to='lab_fil_CompanyPurchasedTwoSecuredPromissoryNotesFromGFarma'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PricePaidInTheNextEquityFinancing' xlink:label='fil_PricePaidInTheNextEquityFinancing'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PricePaidInTheNextEquityFinancing' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price paid in the Next Equity Financing</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PricePaidInTheNextEquityFinancing' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Price paid in the Next Equity Financing</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PricePaidInTheNextEquityFinancing' xlink:to='lab_fil_PricePaidInTheNextEquityFinancing'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ElectrumPartnersLlcConvertibleNoteReceivableIncludingAccruedInterest' xlink:label='fil_ElectrumPartnersLlcConvertibleNoteReceivableIncludingAccruedInterest'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ElectrumPartnersLlcConvertibleNoteReceivableIncludingAccruedInterest' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Electrum Partners, LLC convertible note receivable including accrued interest</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ElectrumPartnersLlcConvertibleNoteReceivableIncludingAccruedInterest' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Electrum Partners, LLC convertible note receivable including accrued interest</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ElectrumPartnersLlcConvertibleNoteReceivableIncludingAccruedInterest' xlink:to='lab_fil_ElectrumPartnersLlcConvertibleNoteReceivableIncludingAccruedInterest'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_AccruedInterest' xlink:label='fil_AccruedInterest'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccruedInterest' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrued interest {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccruedInterest' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Accrued interest</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccruedInterest' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Accrued interest on receivables.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AccruedInterest' xlink:to='lab_fil_AccruedInterest'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_JudgmentAccruesInterestAtTheRateOf' xlink:label='fil_JudgmentAccruesInterestAtTheRateOf'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_JudgmentAccruesInterestAtTheRateOf' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Judgment accrues interest at the rate of</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_JudgmentAccruesInterestAtTheRateOf' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Judgment accrues interest at the rate of</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_JudgmentAccruesInterestAtTheRateOf' xlink:to='lab_fil_JudgmentAccruesInterestAtTheRateOf'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_SignificantAccountingPoliciesAccountsReceivableAbstract' xlink:label='fil_SignificantAccountingPoliciesAccountsReceivableAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_SignificantAccountingPoliciesAccountsReceivableAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Significant accounting policies Accounts receivable:</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_SignificantAccountingPoliciesAccountsReceivableAbstract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company raised from warrant redemption fees</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_SignificantAccountingPoliciesAccountsReceivableAbstract' xlink:to='lab_fil_SignificantAccountingPoliciesAccountsReceivableAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock' xlink:label='us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of an outstanding liability to its Chief Executive Officer (&quot;CEO&quot;) as follows (Tables)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock' xlink:to='lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ScheduleOfInvestmentInAccountReceivableTablesAbstract' xlink:label='fil_ScheduleOfInvestmentInAccountReceivableTablesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ScheduleOfInvestmentInAccountReceivableTablesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Investment in account receivable (Tables):</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ScheduleOfInvestmentInAccountReceivableTablesAbstract' xlink:to='lab_fil_ScheduleOfInvestmentInAccountReceivableTablesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_InvestmentInAccountReceivableNetOfDiscountPolicyTextBlock' xlink:label='fil_InvestmentInAccountReceivableNetOfDiscountPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InvestmentInAccountReceivableNetOfDiscountPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Investment in account receivable, net of discount</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InvestmentInAccountReceivableNetOfDiscountPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The entire policy disclosure for Investment in account receivable, net of discount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InvestmentInAccountReceivableNetOfDiscountPolicyTextBlock' xlink:to='lab_fil_InvestmentInAccountReceivableNetOfDiscountPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock' xlink:label='us-gaap_ReceivablesPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ReceivablesPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounts receivable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ReceivablesPolicyTextBlock' xlink:to='lab_us-gaap_ReceivablesPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesOfLesseeDisclosureTextBlock' xlink:label='us-gaap_LeasesOfLesseeDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LeasesOfLesseeDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Lease commitments</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LeasesOfLesseeDisclosureTextBlock' xlink:to='lab_us-gaap_LeasesOfLesseeDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net cash provided by (used by) investing activities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:to='lab_us-gaap_NetCashProvidedByUsedInInvestingActivities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss' xlink:label='us-gaap_ProfitLoss'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProfitLoss' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net income (loss) {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProfitLoss' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Net income (loss)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ProfitLoss' xlink:to='lab_us-gaap_ProfitLoss'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued' xlink:label='us-gaap_PreferredStockSharesIssued'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PreferredStockSharesIssued' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred stock, Shares Issued</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PreferredStockSharesIssued' xlink:to='lab_us-gaap_PreferredStockSharesIssued'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ConvertibleNotesReceivableCurrentPortion' xlink:label='fil_ConvertibleNotesReceivableCurrentPortion'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertibleNotesReceivableCurrentPortion' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Convertible notes receivable, current portion</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertibleNotesReceivableCurrentPortion' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Convertible notes receivable, current portion</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConvertibleNotesReceivableCurrentPortion' xlink:to='lab_fil_ConvertibleNotesReceivableCurrentPortion'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Investments' xlink:label='us-gaap_Investments'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Investments' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Investment in accounts receivable, current portion, net of discount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Investments' xlink:to='lab_us-gaap_Investments'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract' xlink:label='us-gaap_AssetsCurrentAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AssetsCurrentAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='lab_us-gaap_AssetsCurrentAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus' xlink:label='dei_DocumentFiscalPeriodFocus'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentFiscalPeriodFocus' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document Fiscal Period Focus</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentFiscalPeriodFocus' xlink:to='lab_dei_DocumentFiscalPeriodFocus'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_GainsLossesReclassifiedFromAccumulatedOtherComprehensiveIncomeToNetIncome' xlink:label='fil_GainsLossesReclassifiedFromAccumulatedOtherComprehensiveIncomeToNetIncome'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_GainsLossesReclassifiedFromAccumulatedOtherComprehensiveIncomeToNetIncome' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>(Gains) Losses reclassified from accumulated other comprehensive income to net income</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_GainsLossesReclassifiedFromAccumulatedOtherComprehensiveIncomeToNetIncome' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>(Gains) Losses reclassified from accumulated other comprehensive income to net income</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_GainsLossesReclassifiedFromAccumulatedOtherComprehensiveIncomeToNetIncome' xlink:to='lab_fil_GainsLossesReclassifiedFromAccumulatedOtherComprehensiveIncomeToNetIncome'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_TotalAssets2' xlink:label='fil_TotalAssets2'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalAssets2' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total assets. {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalAssets2' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Total assets.</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalAssets2' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalAssets2' xlink:to='lab_fil_TotalAssets2'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_BhangAgreementHaveTheOptionToReturnAllOrPartOfThoseSharesInExchangeForPaymentOfTheOriginalPurchasePriceOf195PerSharePlusAProRataAmount1' xlink:label='fil_BhangAgreementHaveTheOptionToReturnAllOrPartOfThoseSharesInExchangeForPaymentOfTheOriginalPurchasePriceOf195PerSharePlusAProRataAmount1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BhangAgreementHaveTheOptionToReturnAllOrPartOfThoseSharesInExchangeForPaymentOfTheOriginalPurchasePriceOf195PerSharePlusAProRataAmount1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Bhang Agreement have the option to return all or part of those shares in exchange for payment of the original purchase price of $1.95 per share plus a pro-rata amount.</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_BhangAgreementHaveTheOptionToReturnAllOrPartOfThoseSharesInExchangeForPaymentOfTheOriginalPurchasePriceOf195PerSharePlusAProRataAmount1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Bhang Agreement have the option to return all or part of those shares in exchange for payment of the original purchase price of $1.95 per share plus a pro-rata amount.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BhangAgreementHaveTheOptionToReturnAllOrPartOfThoseSharesInExchangeForPaymentOfTheOriginalPurchasePriceOf195PerSharePlusAProRataAmount1' xlink:to='lab_fil_BhangAgreementHaveTheOptionToReturnAllOrPartOfThoseSharesInExchangeForPaymentOfTheOriginalPurchasePriceOf195PerSharePlusAProRataAmount1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_CommitmentsAndContingenciesDetailsAbstract' xlink:label='fil_CommitmentsAndContingenciesDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommitmentsAndContingenciesDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Commitments and contingencies details</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommitmentsAndContingenciesDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company paid for credit default insurance to a third party as required by the lender on an international loan facility.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CommitmentsAndContingenciesDetailsAbstract' xlink:to='lab_fil_CommitmentsAndContingenciesDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_CeoPutHisSharesOwnedInAnEscrow' xlink:label='fil_CeoPutHisSharesOwnedInAnEscrow'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CeoPutHisSharesOwnedInAnEscrow' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>CEO put his shares owned in an escrow</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CeoPutHisSharesOwnedInAnEscrow' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>CEO put his shares owned in an escrow</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CeoPutHisSharesOwnedInAnEscrow' xlink:to='lab_fil_CeoPutHisSharesOwnedInAnEscrow'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_AutoLoanThroughHyundaiMotorFinanceInterestAt299PerAnnumMonthlyPrincipleAndInterestPaymentsOf878MaturingDecember2018' xlink:label='fil_AutoLoanThroughHyundaiMotorFinanceInterestAt299PerAnnumMonthlyPrincipleAndInterestPaymentsOf878MaturingDecember2018'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AutoLoanThroughHyundaiMotorFinanceInterestAt299PerAnnumMonthlyPrincipleAndInterestPaymentsOf878MaturingDecember2018' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Auto loan through Hyundai Motor Finance, interest at 2.99% per annum, monthly principle and interest payments of $878, maturing December 2018.</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AutoLoanThroughHyundaiMotorFinanceInterestAt299PerAnnumMonthlyPrincipleAndInterestPaymentsOf878MaturingDecember2018' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Auto loan through Hyundai Motor Finance, interest at 2.99% per annum, monthly principle and interest payments of $878, maturing December 2018.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AutoLoanThroughHyundaiMotorFinanceInterestAt299PerAnnumMonthlyPrincipleAndInterestPaymentsOf878MaturingDecember2018' xlink:to='lab_fil_AutoLoanThroughHyundaiMotorFinanceInterestAt299PerAnnumMonthlyPrincipleAndInterestPaymentsOf878MaturingDecember2018'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_OutstandingEFGAndHWarrants2' xlink:label='fil_OutstandingEFGAndHWarrants2'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_OutstandingEFGAndHWarrants2' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Outstanding E, F, G and H Warrants {2}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_OutstandingEFGAndHWarrants2' xlink:role='http://www.xbrl.org/2003/role/periodStartLabel' xml:lang='en-US'>Outstanding E, F, G and H Warrants</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_OutstandingEFGAndHWarrants2' xlink:role='http://www.xbrl.org/2003/role/periodEndLabel' xml:lang='en-US'>Outstanding E, F, G and H Warrants</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_OutstandingEFGAndHWarrants2' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of warrants or rights outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_OutstandingEFGAndHWarrants2' xlink:to='lab_fil_OutstandingEFGAndHWarrants2'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_Settlements1' xlink:label='fil_Settlements1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Settlements1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Settlements {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Settlements1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Settlements</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Settlements1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Cash received or short term receivables for unsettled money transfers, money orders, consumer payments, or business to business payments. Settlement assets include clearing and settling customers payments due to and from financial institutions and may include cash and cash equivalents.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Settlements1' xlink:to='lab_fil_Settlements1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_Balance3' xlink:label='fil_Balance3'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Balance3' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Balance {2}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Balance3' xlink:role='http://www.xbrl.org/2003/role/periodStartLabel' xml:lang='en-US'>Balance</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Balance3' xlink:role='http://www.xbrl.org/2003/role/periodEndLabel' xml:lang='en-US'>Balance</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Balance3' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Balance</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Balance3' xlink:to='lab_fil_Balance3'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis' xlink:label='us-gaap_StatementEquityComponentsAxis'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StatementEquityComponentsAxis' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Equity Components [Axis]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='lab_us-gaap_StatementEquityComponentsAxis'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_GFarmaPurchasedRestrictedSharesOfTheCompanySCommonStock' xlink:label='fil_GFarmaPurchasedRestrictedSharesOfTheCompanySCommonStock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_GFarmaPurchasedRestrictedSharesOfTheCompanySCommonStock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>G Farma purchased restricted shares of the Company&apos;s Common Stock</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_GFarmaPurchasedRestrictedSharesOfTheCompanySCommonStock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Farma purchased restricted shares of the Company&apos;s Common Stock</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_GFarmaPurchasedRestrictedSharesOfTheCompanySCommonStock' xlink:to='lab_fil_GFarmaPurchasedRestrictedSharesOfTheCompanySCommonStock'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_SecondPromissoryNoteIsUsedForWorkingCapital' xlink:label='fil_SecondPromissoryNoteIsUsedForWorkingCapital'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_SecondPromissoryNoteIsUsedForWorkingCapital' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Second promissory note is used for working capital</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_SecondPromissoryNoteIsUsedForWorkingCapital' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Second promissory note is used for working capital</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_SecondPromissoryNoteIsUsedForWorkingCapital' xlink:to='lab_fil_SecondPromissoryNoteIsUsedForWorkingCapital'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_NeucourtIncConvertibleNoteReceivableIncludingAccruedInterest' xlink:label='fil_NeucourtIncConvertibleNoteReceivableIncludingAccruedInterest'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NeucourtIncConvertibleNoteReceivableIncludingAccruedInterest' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>NeuCourt, Inc. convertible note receivable including accrued interest</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NeucourtIncConvertibleNoteReceivableIncludingAccruedInterest' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>NeuCourt, Inc. convertible note receivable including accrued interest</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NeucourtIncConvertibleNoteReceivableIncludingAccruedInterest' xlink:to='lab_fil_NeucourtIncConvertibleNoteReceivableIncludingAccruedInterest'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_AccumulatedDepreciationAndAmortization' xlink:label='fil_AccumulatedDepreciationAndAmortization'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccumulatedDepreciationAndAmortization' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accumulated depreciation and amortization {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccumulatedDepreciationAndAmortization' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Accumulated depreciation and amortization</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccumulatedDepreciationAndAmortization' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AccumulatedDepreciationAndAmortization' xlink:to='lab_fil_AccumulatedDepreciationAndAmortization'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_CurrentPortion' xlink:label='fil_CurrentPortion'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CurrentPortion' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current portion *</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CurrentPortion' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Current portion</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CurrentPortion' xlink:to='lab_fil_CurrentPortion'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_GoodwillRelatedToToThe1999Acquisition' xlink:label='fil_GoodwillRelatedToToThe1999Acquisition'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_GoodwillRelatedToToThe1999Acquisition' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Goodwill related to to the 1999 acquisition</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_GoodwillRelatedToToThe1999Acquisition' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Goodwill related to to the 1999 acquisition</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_GoodwillRelatedToToThe1999Acquisition' xlink:to='lab_fil_GoodwillRelatedToToThe1999Acquisition'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_CompensationRelatedCostsRetirementBenefitsAbstract' xlink:label='fil_CompensationRelatedCostsRetirementBenefitsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompensationRelatedCostsRetirementBenefitsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of an outstanding liability to its Chief Executive Officer (&quot;CEO&quot;) as follows (Tables):</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompensationRelatedCostsRetirementBenefitsAbstract' xlink:to='lab_fil_CompensationRelatedCostsRetirementBenefitsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock' xlink:label='us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of remaining annual minimum lease payments under the non-cancelable operating leases</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtPolicyTextBlock' xlink:label='us-gaap_DebtPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DebtPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Notes receivable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DebtPolicyTextBlock' xlink:to='lab_us-gaap_DebtPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PatentAndLicenseFeeFacilityWithLarsonAbstract' xlink:label='fil_PatentAndLicenseFeeFacilityWithLarsonAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PatentAndLicenseFeeFacilityWithLarsonAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Patent and License Fee Facility with Larson</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PatentAndLicenseFeeFacilityWithLarsonAbstract' xlink:to='lab_fil_PatentAndLicenseFeeFacilityWithLarsonAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_WarrantsRedemptionLiabilityTextBlock' xlink:label='fil_WarrantsRedemptionLiabilityTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsRedemptionLiabilityTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrants redemption liability</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsRedemptionLiabilityTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The entire disclosure is about the Company&apos;s Warrant redemption liability</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantsRedemptionLiabilityTextBlock' xlink:to='lab_fil_WarrantsRedemptionLiabilityTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsDisclosureTextBlock' xlink:label='us-gaap_OtherAssetsDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherAssetsDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Prepaid expenses and other assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherAssetsDisclosureTextBlock' xlink:to='lab_us-gaap_OtherAssetsDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants' xlink:label='us-gaap_ProceedsFromIssuanceOfWarrants'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProceedsFromIssuanceOfWarrants' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrants converted to common stock, net of costs</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ProceedsFromIssuanceOfWarrants' xlink:to='lab_us-gaap_ProceedsFromIssuanceOfWarrants'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract' xlink:label='us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Increase (decrease) in operating liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract' xlink:to='lab_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_NetLoss' xlink:label='fil_NetLoss'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetLoss' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net loss.</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetLoss' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NetLoss' xlink:to='lab_fil_NetLoss'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted' xlink:label='us-gaap_EarningsPerShareBasicAndDiluted'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EarningsPerShareBasicAndDiluted' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Basic and diluted.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EarningsPerShareBasicAndDiluted' xlink:to='lab_us-gaap_EarningsPerShareBasicAndDiluted'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_LossOnDisposalOfInvestorWebcastAssetsAndLiabilities' xlink:label='fil_LossOnDisposalOfInvestorWebcastAssetsAndLiabilities'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LossOnDisposalOfInvestorWebcastAssetsAndLiabilities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Loss on disposal of Investor Webcast assets and liabilities</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LossOnDisposalOfInvestorWebcastAssetsAndLiabilities' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Loss on disposal of Investor Webcast assets and liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LossOnDisposalOfInvestorWebcastAssetsAndLiabilities' xlink:to='lab_fil_LossOnDisposalOfInvestorWebcastAssetsAndLiabilities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:label='us-gaap_LiabilitiesAndStockholdersEquityAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>LIABILITIES AND SHAREHOLDERS&apos; EQUITY</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:to='lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DueFromEmployeesCurrent' xlink:label='us-gaap_DueFromEmployeesCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DueFromEmployeesCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Employee advances</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DueFromEmployeesCurrent' xlink:to='lab_us-gaap_DueFromEmployeesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestReceivable' xlink:label='us-gaap_InterestReceivable'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InterestReceivable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest receivable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InterestReceivable' xlink:to='lab_us-gaap_InterestReceivable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers' xlink:label='dei_EntityVoluntaryFilers'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityVoluntaryFilers' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Voluntary Filers</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityVoluntaryFilers' xlink:to='lab_dei_EntityVoluntaryFilers'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_FarmaAlsoPurchasedAnAdditionalSharesOfCompanyCommonStockAtPerShare' xlink:label='fil_FarmaAlsoPurchasedAnAdditionalSharesOfCompanyCommonStockAtPerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_FarmaAlsoPurchasedAnAdditionalSharesOfCompanyCommonStockAtPerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Farma also purchased an additional shares of Company Common Stock at per share</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_FarmaAlsoPurchasedAnAdditionalSharesOfCompanyCommonStockAtPerShare' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Farma also purchased an additional shares of Company Common Stock at per share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_FarmaAlsoPurchasedAnAdditionalSharesOfCompanyCommonStockAtPerShare' xlink:to='lab_fil_FarmaAlsoPurchasedAnAdditionalSharesOfCompanyCommonStockAtPerShare'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_LessTaxTaxBenefit1' xlink:label='fil_LessTaxTaxBenefit1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LessTaxTaxBenefit1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Less: Tax (tax benefit) {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LessTaxTaxBenefit1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Less: Tax (tax benefit)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LessTaxTaxBenefit1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Less: Tax (tax benefit)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LessTaxTaxBenefit1' xlink:to='lab_fil_LessTaxTaxBenefit1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ReconcilesOperatingSegmentsAndCorporateUnallocatedOperatingIncomeLossDetailsAbstract' xlink:label='fil_ReconcilesOperatingSegmentsAndCorporateUnallocatedOperatingIncomeLossDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ReconcilesOperatingSegmentsAndCorporateUnallocatedOperatingIncomeLossDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Reconciles operating segments and corporate-unallocated operating income (loss) Details</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ReconcilesOperatingSegmentsAndCorporateUnallocatedOperatingIncomeLossDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Income before taxes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ReconcilesOperatingSegmentsAndCorporateUnallocatedOperatingIncomeLossDetailsAbstract' xlink:to='lab_fil_ReconcilesOperatingSegmentsAndCorporateUnallocatedOperatingIncomeLossDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_NetSales1' xlink:label='fil_NetSales1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetSales1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net sales</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetSales1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NetSales1' xlink:to='lab_fil_NetSales1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_FutureMinimumLeasePayments2020' xlink:label='fil_FutureMinimumLeasePayments2020'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_FutureMinimumLeasePayments2020' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Future minimum lease payments 2020</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_FutureMinimumLeasePayments2020' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Future minimum lease payments 2020</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_FutureMinimumLeasePayments2020' xlink:to='lab_fil_FutureMinimumLeasePayments2020'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_Outstanding1' xlink:label='fil_Outstanding1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Outstanding1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Outstanding {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Outstanding1' xlink:role='http://www.xbrl.org/2003/role/periodStartLabel' xml:lang='en-US'>Outstanding</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Outstanding1' xlink:role='http://www.xbrl.org/2003/role/periodEndLabel' xml:lang='en-US'>Outstanding</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Outstanding1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of shares issued which are neither cancelled nor held in the treasury.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Outstanding1' xlink:to='lab_fil_Outstanding1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_WarrantsDetailsAbstract' xlink:label='fil_WarrantsDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrants Details</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Series B Common Stock Warrant Exercise Price</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantsDetailsAbstract' xlink:to='lab_fil_WarrantsDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_NetPropertyAndEquipment1' xlink:label='fil_NetPropertyAndEquipment1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetPropertyAndEquipment1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net Property and equipment {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetPropertyAndEquipment1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Net Property and equipment</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetPropertyAndEquipment1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Net Property and equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NetPropertyAndEquipment1' xlink:to='lab_fil_NetPropertyAndEquipment1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_LongTermPortion1' xlink:label='fil_LongTermPortion1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LongTermPortion1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Long term portion {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LongTermPortion1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Long term portion</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LongTermPortion1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Long term portion.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LongTermPortion1' xlink:to='lab_fil_LongTermPortion1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ElectrumPartnersLlcConvertibleNoteReceivableIncludingAccruedInterestOf6874And6874Respectively' xlink:label='fil_ElectrumPartnersLlcConvertibleNoteReceivableIncludingAccruedInterestOf6874And6874Respectively'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ElectrumPartnersLlcConvertibleNoteReceivableIncludingAccruedInterestOf6874And6874Respectively' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Electrum Partners, LLC convertible note receivable including accrued interest of $6,874 and $6,874, respectively</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ElectrumPartnersLlcConvertibleNoteReceivableIncludingAccruedInterestOf6874And6874Respectively' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Electrum Partners, LLC convertible note receivable including accrued interest of $6,874 and $6,874, respectively</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ElectrumPartnersLlcConvertibleNoteReceivableIncludingAccruedInterestOf6874And6874Respectively' xlink:to='lab_fil_ElectrumPartnersLlcConvertibleNoteReceivableIncludingAccruedInterestOf6874And6874Respectively'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_CompanyWillReceiveAnInvestmentInAnAccountReceivableWithInstallmentPaymentsPerYearFor11Years' xlink:label='fil_CompanyWillReceiveAnInvestmentInAnAccountReceivableWithInstallmentPaymentsPerYearFor11Years'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyWillReceiveAnInvestmentInAnAccountReceivableWithInstallmentPaymentsPerYearFor11Years' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company will receive an investment in an account receivable with installment payments per year for 11 years</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyWillReceiveAnInvestmentInAnAccountReceivableWithInstallmentPaymentsPerYearFor11Years' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company will receive an investment in an account receivable with installment payments per year for 11 years</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanyWillReceiveAnInvestmentInAnAccountReceivableWithInstallmentPaymentsPerYearFor11Years' xlink:to='lab_fil_CompanyWillReceiveAnInvestmentInAnAccountReceivableWithInstallmentPaymentsPerYearFor11Years'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_BhangRefusedToReturnFollowingRescissionOfTheAgreement' xlink:label='fil_BhangRefusedToReturnFollowingRescissionOfTheAgreement'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BhangRefusedToReturnFollowingRescissionOfTheAgreement' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Bhang refused to return following rescission of the agreement</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_BhangRefusedToReturnFollowingRescissionOfTheAgreement' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Bhang refused to return following rescission of the agreement</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BhangRefusedToReturnFollowingRescissionOfTheAgreement' xlink:to='lab_fil_BhangRefusedToReturnFollowingRescissionOfTheAgreement'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_EarningPerShareDetailsAbstract' xlink:label='fil_EarningPerShareDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_EarningPerShareDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Earning per share Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_EarningPerShareDetailsAbstract' xlink:to='lab_fil_EarningPerShareDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_InterestOnNoteOriginalRate' xlink:label='fil_InterestOnNoteOriginalRate'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestOnNoteOriginalRate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest on note (Original rate)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestOnNoteOriginalRate' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Interest on note (Original rate)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InterestOnNoteOriginalRate' xlink:to='lab_fil_InterestOnNoteOriginalRate'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock' xlink:label='us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Segment Reporting Information, by Segment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock' xlink:to='lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ScheduleOfPrepaidExpenseAndOtherAssetsAbstract' xlink:label='fil_ScheduleOfPrepaidExpenseAndOtherAssetsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ScheduleOfPrepaidExpenseAndOtherAssetsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Prepaid expense and other assets (Tables):</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ScheduleOfPrepaidExpenseAndOtherAssetsAbstract' xlink:to='lab_fil_ScheduleOfPrepaidExpenseAndOtherAssetsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_AccruedSalaryAccruedRetirementAndRelatedPartyIncentiveFeeTextBlockAbstract' xlink:label='fil_AccruedSalaryAccruedRetirementAndRelatedPartyIncentiveFeeTextBlockAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccruedSalaryAccruedRetirementAndRelatedPartyIncentiveFeeTextBlockAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrued salary, accrued retirement and incentive fee - related party</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AccruedSalaryAccruedRetirementAndRelatedPartyIncentiveFeeTextBlockAbstract' xlink:to='lab_fil_AccruedSalaryAccruedRetirementAndRelatedPartyIncentiveFeeTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FinancingReceivablesTextBlock' xlink:label='us-gaap_FinancingReceivablesTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FinancingReceivablesTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Investment in account receivable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FinancingReceivablesTextBlock' xlink:to='lab_us-gaap_FinancingReceivablesTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_NatureOfOperations1Abstract' xlink:label='fil_NatureOfOperations1Abstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NatureOfOperations1Abstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Nature of operations</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NatureOfOperations1Abstract' xlink:to='lab_fil_NatureOfOperations1Abstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ContractualInterestInLegalRecoveryPurchasedThroughIssuance' xlink:label='fil_ContractualInterestInLegalRecoveryPurchasedThroughIssuance'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ContractualInterestInLegalRecoveryPurchasedThroughIssuance' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Contractual interest in legal recovery purchased through issuance of 222,223 shares of restricted common stock in a private offering</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ContractualInterestInLegalRecoveryPurchasedThroughIssuance' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Contractual interest in legal recovery purchased through issuance of 222,223 shares of restricted common stock in a private offering</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ContractualInterestInLegalRecoveryPurchasedThroughIssuance' xlink:to='lab_fil_ContractualInterestInLegalRecoveryPurchasedThroughIssuance'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ShortTermLoanFromRelatedParties' xlink:label='fil_ShortTermLoanFromRelatedParties'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ShortTermLoanFromRelatedParties' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Short term loan from related parties</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ShortTermLoanFromRelatedParties' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Short term loan from related parties</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ShortTermLoanFromRelatedParties' xlink:to='lab_fil_ShortTermLoanFromRelatedParties'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax' xlink:label='us-gaap_ComprehensiveIncomeNetOfTax'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ComprehensiveIncomeNetOfTax' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Comprehensive income</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ComprehensiveIncomeNetOfTax' xlink:to='lab_us-gaap_ComprehensiveIncomeNetOfTax'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic' xlink:label='us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net income (loss) attributable to Mentor</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic' xlink:to='lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense' xlink:label='us-gaap_InterestExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InterestExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest expense</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InterestExpense' xlink:to='lab_us-gaap_InterestExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare' xlink:label='us-gaap_PreferredStockParOrStatedValuePerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PreferredStockParOrStatedValuePerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred stock, Par Value</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PreferredStockParOrStatedValuePerShare' xlink:to='lab_us-gaap_PreferredStockParOrStatedValuePerShare'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross' xlink:label='us-gaap_PropertyPlantAndEquipmentGross'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentGross' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property and equipment {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentGross' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Property and equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentGross' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentGross'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_FixedEquityConversionRatePerShare' xlink:label='fil_FixedEquityConversionRatePerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_FixedEquityConversionRatePerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fixed equity conversion rate per share</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_FixedEquityConversionRatePerShare' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Fixed equity conversion rate per share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_FixedEquityConversionRatePerShare' xlink:to='lab_fil_FixedEquityConversionRatePerShare'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_OtherExpense' xlink:label='fil_OtherExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_OtherExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other expense</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_OtherExpense' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount of expense classified as other</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_OtherExpense' xlink:to='lab_fil_OtherExpense'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_DepreciationAndAmortization3' xlink:label='fil_DepreciationAndAmortization3'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DepreciationAndAmortization3' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Depreciation and amortization.</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_DepreciationAndAmortization3' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DepreciationAndAmortization3' xlink:to='lab_fil_DepreciationAndAmortization3'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_CorporateUnallocatedAndEliminationsAbstract' xlink:label='fil_CorporateUnallocatedAndEliminationsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CorporateUnallocatedAndEliminationsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Corporate unallocated and Eliminations</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CorporateUnallocatedAndEliminationsAbstract' xlink:to='lab_fil_CorporateUnallocatedAndEliminationsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_MentorObtainedAJudgmentInTheAmountAgainstBhangCorporationAndItsPredecessorInInterest' xlink:label='fil_MentorObtainedAJudgmentInTheAmountAgainstBhangCorporationAndItsPredecessorInInterest'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_MentorObtainedAJudgmentInTheAmountAgainstBhangCorporationAndItsPredecessorInInterest' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Mentor obtained a judgment in the amount against Bhang Corporation and its predecessor in interest</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_MentorObtainedAJudgmentInTheAmountAgainstBhangCorporationAndItsPredecessorInInterest' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Mentor obtained a judgment in the amount against Bhang Corporation and its predecessor in interest</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_MentorObtainedAJudgmentInTheAmountAgainstBhangCorporationAndItsPredecessorInInterest' xlink:to='lab_fil_MentorObtainedAJudgmentInTheAmountAgainstBhangCorporationAndItsPredecessorInInterest'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_MentorPaidLarsonChargesAdvancedForEarlyPatentWork' xlink:label='fil_MentorPaidLarsonChargesAdvancedForEarlyPatentWork'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_MentorPaidLarsonChargesAdvancedForEarlyPatentWork' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Mentor paid Larson charges advanced for early patent work</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_MentorPaidLarsonChargesAdvancedForEarlyPatentWork' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Mentor paid Larson charges advanced for early patent work</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_MentorPaidLarsonChargesAdvancedForEarlyPatentWork' xlink:to='lab_fil_MentorPaidLarsonChargesAdvancedForEarlyPatentWork'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_TotalOutstandingLiabilityToChiefExecutiveOfficer' xlink:label='fil_TotalOutstandingLiabilityToChiefExecutiveOfficer'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalOutstandingLiabilityToChiefExecutiveOfficer' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Outstanding liability to Chief Executive Officer</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalOutstandingLiabilityToChiefExecutiveOfficer' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total Outstanding liability to Chief Executive Officer</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalOutstandingLiabilityToChiefExecutiveOfficer' xlink:to='lab_fil_TotalOutstandingLiabilityToChiefExecutiveOfficer'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_LongTermDebtNetOfCurrentPortion' xlink:label='fil_LongTermDebtNetOfCurrentPortion'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LongTermDebtNetOfCurrentPortion' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Long term debt, net of current portion {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LongTermDebtNetOfCurrentPortion' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Long term debt, net of current portion</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LongTermDebtNetOfCurrentPortion' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Carrying amount of long-term debt, net of unamortized discount or premium, including current and noncurrent amounts. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LongTermDebtNetOfCurrentPortion' xlink:to='lab_fil_LongTermDebtNetOfCurrentPortion'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_WciRentsOfficeAndWarehouseSpaceInTempteArizonaAndRentExpensesPaid' xlink:label='fil_WciRentsOfficeAndWarehouseSpaceInTempteArizonaAndRentExpensesPaid'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WciRentsOfficeAndWarehouseSpaceInTempteArizonaAndRentExpensesPaid' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>WCI rents office and warehouse space in Tempte, Arizona and rent expenses paid</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WciRentsOfficeAndWarehouseSpaceInTempteArizonaAndRentExpensesPaid' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WciRentsOfficeAndWarehouseSpaceInTempteArizonaAndRentExpensesPaid' xlink:to='lab_fil_WciRentsOfficeAndWarehouseSpaceInTempteArizonaAndRentExpensesPaid'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PreferredStockSharesParValue' xlink:label='fil_PreferredStockSharesParValue'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PreferredStockSharesParValue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred Stock shares par value</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PreferredStockSharesParValue' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PreferredStockSharesParValue' xlink:to='lab_fil_PreferredStockSharesParValue'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PreferredStock1Abstract' xlink:label='fil_PreferredStock1Abstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PreferredStock1Abstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred Stock:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PreferredStock1Abstract' xlink:to='lab_fil_PreferredStock1Abstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_SeriesH700ExercisePriceMember' xlink:label='fil_SeriesH700ExercisePriceMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_SeriesH700ExercisePriceMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Series H $7.00 exercise price</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_SeriesH700ExercisePriceMember' xlink:to='lab_fil_SeriesH700ExercisePriceMember'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_WeightedAverageContractualLifeForAllMentorWarrants' xlink:label='fil_WeightedAverageContractualLifeForAllMentorWarrants'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageContractualLifeForAllMentorWarrants' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted average contractual life for all Mentor warrants</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageContractualLifeForAllMentorWarrants' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Weighted average contractual life for all Mentor warrants</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WeightedAverageContractualLifeForAllMentorWarrants' xlink:to='lab_fil_WeightedAverageContractualLifeForAllMentorWarrants'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_Issuances1' xlink:label='fil_Issuances1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Issuances1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issuances {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Issuances1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Issuances</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Issuances1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Issuances</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Issuances1' xlink:to='lab_fil_Issuances1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_FairValueMeasurementsAbstract' xlink:label='fil_FairValueMeasurementsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_FairValueMeasurementsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair Value Measurements</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_FairValueMeasurementsAbstract' xlink:to='lab_fil_FairValueMeasurementsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_CompanyPurchasedTwoSecuredPromissoryNotesFromGFarmaBearInterestAtPerAnnum' xlink:label='fil_CompanyPurchasedTwoSecuredPromissoryNotesFromGFarmaBearInterestAtPerAnnum'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyPurchasedTwoSecuredPromissoryNotesFromGFarmaBearInterestAtPerAnnum' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company purchased two secured promissory notes from G Farma bear interest at per annum</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyPurchasedTwoSecuredPromissoryNotesFromGFarmaBearInterestAtPerAnnum' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company purchased two secured promissory notes from G Farma bear interest at per annum</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanyPurchasedTwoSecuredPromissoryNotesFromGFarmaBearInterestAtPerAnnum' xlink:to='lab_fil_CompanyPurchasedTwoSecuredPromissoryNotesFromGFarmaBearInterestAtPerAnnum'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_MentorSharesExchangedForAllOrPartOfTheInstallmentPayments' xlink:label='fil_MentorSharesExchangedForAllOrPartOfTheInstallmentPayments'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_MentorSharesExchangedForAllOrPartOfTheInstallmentPayments' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Mentor shares exchanged for all or part of the installment payments</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_MentorSharesExchangedForAllOrPartOfTheInstallmentPayments' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Mentor shares exchanged for all or part of the installment payments</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_MentorSharesExchangedForAllOrPartOfTheInstallmentPayments' xlink:to='lab_fil_MentorSharesExchangedForAllOrPartOfTheInstallmentPayments'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PaymentOfTheOriginalPurchasePricePlusAProRataAmount' xlink:label='fil_PaymentOfTheOriginalPurchasePricePlusAProRataAmount'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PaymentOfTheOriginalPurchasePricePlusAProRataAmount' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Payment of the original purchase price plus a pro-rata amount</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PaymentOfTheOriginalPurchasePricePlusAProRataAmount' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Payment of the original purchase price plus a pro-rata amount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PaymentOfTheOriginalPurchasePricePlusAProRataAmount' xlink:to='lab_fil_PaymentOfTheOriginalPurchasePricePlusAProRataAmount'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_InvestmentInAccountReceivableNetOfDiscountNarrativeAbstract' xlink:label='fil_InvestmentInAccountReceivableNetOfDiscountNarrativeAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InvestmentInAccountReceivableNetOfDiscountNarrativeAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Investment in account receivable, net of discount (Narrative)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InvestmentInAccountReceivableNetOfDiscountNarrativeAbstract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Interest on note</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InvestmentInAccountReceivableNetOfDiscountNarrativeAbstract' xlink:to='lab_fil_InvestmentInAccountReceivableNetOfDiscountNarrativeAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_MonthlyPaymentsOfPrincipalAndInterest' xlink:label='fil_MonthlyPaymentsOfPrincipalAndInterest'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_MonthlyPaymentsOfPrincipalAndInterest' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Monthly payments of principal and interest</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_MonthlyPaymentsOfPrincipalAndInterest' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Monthly payments of principal and interest</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_MonthlyPaymentsOfPrincipalAndInterest' xlink:to='lab_fil_MonthlyPaymentsOfPrincipalAndInterest'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_JudgmentIsComprisedOfInvestedByMentorIntoBhangPlus' xlink:label='fil_JudgmentIsComprisedOfInvestedByMentorIntoBhangPlus'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_JudgmentIsComprisedOfInvestedByMentorIntoBhangPlus' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Judgment is comprised of invested by Mentor into Bhang plus</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_JudgmentIsComprisedOfInvestedByMentorIntoBhangPlus' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Judgment is comprised of invested by Mentor into Bhang plus</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_JudgmentIsComprisedOfInvestedByMentorIntoBhangPlus' xlink:to='lab_fil_JudgmentIsComprisedOfInvestedByMentorIntoBhangPlus'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_LeasesAbstract1' xlink:label='fil_LeasesAbstract1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LeasesAbstract1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of remaining annual minimum lease payments under the non-cancelable operating leases (Tables):</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LeasesAbstract1' xlink:to='lab_fil_LeasesAbstract1'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock' xlink:label='us-gaap_AdvertisingCostsPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AdvertisingCostsPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Advertising and promotion</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AdvertisingCostsPolicyTextBlock' xlink:to='lab_us-gaap_AdvertisingCostsPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock' xlink:label='us-gaap_CommitmentsAndContingenciesDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Commitments and Contingencies Disclosure</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommitmentsAndContingenciesDisclosureTextBlock' xlink:to='lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PatentAndLicenseFeeFacilityWithLarsonTextBlock' xlink:label='fil_PatentAndLicenseFeeFacilityWithLarsonTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PatentAndLicenseFeeFacilityWithLarsonTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Patent and License Fee Facility with Larson {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PatentAndLicenseFeeFacilityWithLarsonTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Patent and License Fee Facility with Larson</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PatentAndLicenseFeeFacilityWithLarsonTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Patent and License Fee Facility with Larson</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PatentAndLicenseFeeFacilityWithLarsonTextBlock' xlink:to='lab_fil_PatentAndLicenseFeeFacilityWithLarsonTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_CommonStockWarrantsAbstract' xlink:label='fil_CommonStockWarrantsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonStockWarrantsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common stock warrants:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CommonStockWarrantsAbstract' xlink:to='lab_fil_CommonStockWarrantsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ContractualInterestInLegalRecoveryAbstract' xlink:label='fil_ContractualInterestInLegalRecoveryAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ContractualInterestInLegalRecoveryAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Contractual interest in legal recovery {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ContractualInterestInLegalRecoveryAbstract' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Contractual interest in legal recovery</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ContractualInterestInLegalRecoveryAbstract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Contractual interest in legal recovery</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ContractualInterestInLegalRecoveryAbstract' xlink:to='lab_fil_ContractualInterestInLegalRecoveryAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:label='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net change in cash</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:to='lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromInterestAndDividendsReceived' xlink:label='us-gaap_ProceedsFromInterestAndDividendsReceived'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProceedsFromInterestAndDividendsReceived' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Non-controlling interest distribution</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ProceedsFromInterestAndDividendsReceived' xlink:to='lab_us-gaap_ProceedsFromInterestAndDividendsReceived'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted' xlink:label='us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Basic and diluted</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted' xlink:to='lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss' xlink:label='us-gaap_OperatingIncomeLoss'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingIncomeLoss' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Operating income (loss)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingIncomeLoss' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Operating income (loss)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OperatingIncomeLoss' xlink:to='lab_us-gaap_OperatingIncomeLoss'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit' xlink:label='us-gaap_GrossProfit'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_GrossProfit' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Gross profit</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_GrossProfit' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Gross profit</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_GrossProfit' xlink:to='lab_us-gaap_GrossProfit'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenuesAbstract' xlink:label='us-gaap_RevenuesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RevenuesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Revenue</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RevenuesAbstract' xlink:to='lab_us-gaap_RevenuesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding' xlink:label='us-gaap_CommonStockSharesOutstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common Stock, Shares Outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockSharesOutstanding' xlink:to='lab_us-gaap_CommonStockSharesOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities' xlink:label='us-gaap_Liabilities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Liabilities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Liabilities' xlink:to='lab_us-gaap_Liabilities'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_MonthlyPrincipalAndInterestPaymentsOnTheWorkingCapitalNoteWillIncreaseFrom3505PerMonthTo' xlink:label='fil_MonthlyPrincipalAndInterestPaymentsOnTheWorkingCapitalNoteWillIncreaseFrom3505PerMonthTo'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_MonthlyPrincipalAndInterestPaymentsOnTheWorkingCapitalNoteWillIncreaseFrom3505PerMonthTo' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Monthly principal and interest payments on the working capital note will increase from $3,505 per month to</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_MonthlyPrincipalAndInterestPaymentsOnTheWorkingCapitalNoteWillIncreaseFrom3505PerMonthTo' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Monthly principal and interest payments on the working capital note will increase from $3,505 per month to</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_MonthlyPrincipalAndInterestPaymentsOnTheWorkingCapitalNoteWillIncreaseFrom3505PerMonthTo' xlink:to='lab_fil_MonthlyPrincipalAndInterestPaymentsOnTheWorkingCapitalNoteWillIncreaseFrom3505PerMonthTo'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ShareholdersHoldSeriesBWarrantsWillReceivePerWarrantRedemptionPayment' xlink:label='fil_ShareholdersHoldSeriesBWarrantsWillReceivePerWarrantRedemptionPayment'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ShareholdersHoldSeriesBWarrantsWillReceivePerWarrantRedemptionPayment' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Shareholders hold Series B Warrants will receive per warrant redemption payment</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ShareholdersHoldSeriesBWarrantsWillReceivePerWarrantRedemptionPayment' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Shareholders hold Series B Warrants will receive per warrant redemption payment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ShareholdersHoldSeriesBWarrantsWillReceivePerWarrantRedemptionPayment' xlink:to='lab_fil_ShareholdersHoldSeriesBWarrantsWillReceivePerWarrantRedemptionPayment'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_OtherComprehensiveIncomeLossNetOfTax2' xlink:label='fil_OtherComprehensiveIncomeLossNetOfTax2'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_OtherComprehensiveIncomeLossNetOfTax2' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other comprehensive income (loss), net of tax</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_OtherComprehensiveIncomeLossNetOfTax2' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Other comprehensive income (loss), net of tax</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_OtherComprehensiveIncomeLossNetOfTax2' xlink:to='lab_fil_OtherComprehensiveIncomeLossNetOfTax2'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PropertyAdditions3' xlink:label='fil_PropertyAdditions3'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PropertyAdditions3' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property additions;</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PropertyAdditions3' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Consolidated - Property Additions</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PropertyAdditions3' xlink:to='lab_fil_PropertyAdditions3'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_IncomeBeforeTaxes1' xlink:label='fil_IncomeBeforeTaxes1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncomeBeforeTaxes1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Income before taxes {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncomeBeforeTaxes1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Income before taxes</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncomeBeforeTaxes1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Income before taxes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IncomeBeforeTaxes1' xlink:to='lab_fil_IncomeBeforeTaxes1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_BonusIncreaseInMarketCapitalization' xlink:label='fil_BonusIncreaseInMarketCapitalization'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BonusIncreaseInMarketCapitalization' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Bonus increase in market capitalization</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_BonusIncreaseInMarketCapitalization' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Bonus increase in market capitalization</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BonusIncreaseInMarketCapitalization' xlink:to='lab_fil_BonusIncreaseInMarketCapitalization'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_MonthlyPrincipalAndInterestPaymentsOnAutoLoansThroughHyundaiMotorFinance' xlink:label='fil_MonthlyPrincipalAndInterestPaymentsOnAutoLoansThroughHyundaiMotorFinance'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_MonthlyPrincipalAndInterestPaymentsOnAutoLoansThroughHyundaiMotorFinance' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Monthly principal and interest payments on auto loans through Hyundai Motor Finance</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_MonthlyPrincipalAndInterestPaymentsOnAutoLoansThroughHyundaiMotorFinance' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Monthly principal and interest payments on auto loans through Hyundai Motor Finance</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_MonthlyPrincipalAndInterestPaymentsOnAutoLoansThroughHyundaiMotorFinance' xlink:to='lab_fil_MonthlyPrincipalAndInterestPaymentsOnAutoLoansThroughHyundaiMotorFinance'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_FutureMinimumLeasePayments2017' xlink:label='fil_FutureMinimumLeasePayments2017'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_FutureMinimumLeasePayments2017' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Future minimum lease payments 2017</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_FutureMinimumLeasePayments2017' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Future minimum lease payments 2017</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_FutureMinimumLeasePayments2017' xlink:to='lab_fil_FutureMinimumLeasePayments2017'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_SharesHaveBeenRepurchasedAndRetired' xlink:label='fil_SharesHaveBeenRepurchasedAndRetired'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_SharesHaveBeenRepurchasedAndRetired' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Shares have been repurchased and retired</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_SharesHaveBeenRepurchasedAndRetired' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Shares have been repurchased and retired</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_SharesHaveBeenRepurchasedAndRetired' xlink:to='lab_fil_SharesHaveBeenRepurchasedAndRetired'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_NumberOfAuthorizedSharesOfCommonStockBeforeReduced' xlink:label='fil_NumberOfAuthorizedSharesOfCommonStockBeforeReduced'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NumberOfAuthorizedSharesOfCommonStockBeforeReduced' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Number of authorized shares of Common Stock before reduced</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NumberOfAuthorizedSharesOfCommonStockBeforeReduced' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of authorized shares of Common Stock before reduced</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NumberOfAuthorizedSharesOfCommonStockBeforeReduced' xlink:to='lab_fil_NumberOfAuthorizedSharesOfCommonStockBeforeReduced'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_WarrantsExercised1' xlink:label='fil_WarrantsExercised1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsExercised1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrants Exercised {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsExercised1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Warrants Exercised</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsExercised1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Warrants Exercised</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantsExercised1' xlink:to='lab_fil_WarrantsExercised1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_SeriesDMember' xlink:label='fil_SeriesDMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_SeriesDMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Series D {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_SeriesDMember' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Series D</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_SeriesDMember' xlink:to='lab_fil_SeriesDMember'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_GFarmaPurchasedAnAdditionalSharesOfTheCompanySCommonStock' xlink:label='fil_GFarmaPurchasedAnAdditionalSharesOfTheCompanySCommonStock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_GFarmaPurchasedAnAdditionalSharesOfTheCompanySCommonStock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>G Farma purchased an additional shares of the Company&apos;s Common Stock</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_GFarmaPurchasedAnAdditionalSharesOfTheCompanySCommonStock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>G Farma purchased an additional shares of the Company&apos;s Common Stock</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_GFarmaPurchasedAnAdditionalSharesOfTheCompanySCommonStock' xlink:to='lab_fil_GFarmaPurchasedAnAdditionalSharesOfTheCompanySCommonStock'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PropertyAndEquipmentIsComprisedOfTheFollowingAbstract' xlink:label='fil_PropertyAndEquipmentIsComprisedOfTheFollowingAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PropertyAndEquipmentIsComprisedOfTheFollowingAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property and equipment is comprised of the following</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PropertyAndEquipmentIsComprisedOfTheFollowingAbstract' xlink:to='lab_fil_PropertyAndEquipmentIsComprisedOfTheFollowingAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_FaceValue' xlink:label='fil_FaceValue'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_FaceValue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Face value</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_FaceValue' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Face value</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_FaceValue' xlink:to='lab_fil_FaceValue'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ReceivableFromBhangChocolateCompany1' xlink:label='fil_ReceivableFromBhangChocolateCompany1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ReceivableFromBhangChocolateCompany1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Receivable from Bhang Chocolate Company {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ReceivableFromBhangChocolateCompany1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Receivable from Bhang Chocolate Company</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ReceivableFromBhangChocolateCompany1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Receivable from Bhang Chocolate Company</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ReceivableFromBhangChocolateCompany1' xlink:to='lab_fil_ReceivableFromBhangChocolateCompany1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ComputationOfDilutiveWeightedAverageNumberOfSharesOutstanding' xlink:label='fil_ComputationOfDilutiveWeightedAverageNumberOfSharesOutstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ComputationOfDilutiveWeightedAverageNumberOfSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Computation of dilutive weighted average number of shares outstanding</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ComputationOfDilutiveWeightedAverageNumberOfSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Computation of dilutive weighted average number of shares outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ComputationOfDilutiveWeightedAverageNumberOfSharesOutstanding' xlink:to='lab_fil_ComputationOfDilutiveWeightedAverageNumberOfSharesOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ScheduleOfSegmentsTablesAbstract' xlink:label='fil_ScheduleOfSegmentsTablesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ScheduleOfSegmentsTablesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Segments (Tables)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ScheduleOfSegmentsTablesAbstract' xlink:to='lab_fil_ScheduleOfSegmentsTablesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_SubsequentEventsAbstract1' xlink:label='fil_SubsequentEventsAbstract1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_SubsequentEventsAbstract1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Subsequent events:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_SubsequentEventsAbstract1' xlink:to='lab_fil_SubsequentEventsAbstract1'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock' xlink:label='us-gaap_SegmentReportingDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SegmentReportingDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Segment Information</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SegmentReportingDisclosureTextBlock' xlink:to='lab_us-gaap_SegmentReportingDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_SegmentReportingAbstract1' xlink:label='fil_SegmentReportingAbstract1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_SegmentReportingAbstract1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Segment Information:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_SegmentReportingAbstract1' xlink:to='lab_fil_SegmentReportingAbstract1'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment' xlink:label='us-gaap_PaymentsToAcquirePropertyPlantAndEquipment'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Purchases of property and equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PaymentsToAcquirePropertyPlantAndEquipment' xlink:to='lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue' xlink:label='us-gaap_IncreaseDecreaseInDeferredRevenue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInDeferredRevenue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Deferred revenue</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInDeferredRevenue' xlink:to='lab_us-gaap_IncreaseDecreaseInDeferredRevenue'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_LossOnDisposalOfInvestorWebcastAssetsAndLiabilities1' xlink:label='fil_LossOnDisposalOfInvestorWebcastAssetsAndLiabilities1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LossOnDisposalOfInvestorWebcastAssetsAndLiabilities1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Loss on disposal of Investor Webcast assets and liabilities.</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LossOnDisposalOfInvestorWebcastAssetsAndLiabilities1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Loss on disposal of Investor Webcast assets and liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LossOnDisposalOfInvestorWebcastAssetsAndLiabilities1' xlink:to='lab_fil_LossOnDisposalOfInvestorWebcastAssetsAndLiabilities1'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract' xlink:label='us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Comprehensive Income</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract' xlink:to='lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestIncomeExpenseNet' xlink:label='us-gaap_InterestIncomeExpenseNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InterestIncomeExpenseNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest income</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InterestIncomeExpenseNet' xlink:to='lab_us-gaap_InterestIncomeExpenseNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract' xlink:label='us-gaap_StockholdersEquityAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquityAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Shareholders&apos; equity</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='lab_us-gaap_StockholdersEquityAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent' xlink:label='us-gaap_LiabilitiesCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total current liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='lab_us-gaap_LiabilitiesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName' xlink:label='dei_EntityRegistrantName'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityRegistrantName' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Registrant Name</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityRegistrantName' xlink:to='lab_dei_EntityRegistrantName'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_MonthlyPrincipalAndInterestPaymentsToTheCompany' xlink:label='fil_MonthlyPrincipalAndInterestPaymentsToTheCompany'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_MonthlyPrincipalAndInterestPaymentsToTheCompany' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Monthly principal and interest payments to the Company</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_MonthlyPrincipalAndInterestPaymentsToTheCompany' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Monthly principal and interest payments to the Company</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_MonthlyPrincipalAndInterestPaymentsToTheCompany' xlink:to='lab_fil_MonthlyPrincipalAndInterestPaymentsToTheCompany'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_GainLossOnInvestments1' xlink:label='fil_GainLossOnInvestments1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_GainLossOnInvestments1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Gain (loss) on investments {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_GainLossOnInvestments1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Gain (loss) on investments</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_GainLossOnInvestments1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>This item represents the net total realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including the unrealized holding gain (loss) of held-to-maturity securities transferred to the trading security category and the cumulative unrealized gain (loss) which was included in other comprehensive income (a separate component of shareholders&apos; equity) for available-for-sale securities transferred to trading securities during the period. Additionally, this item would include any gains (losses) realized during the period from the sale of investments accounted for under the cost method of accounting and losses recognized for other than temporary impairments (OTTI) of the subject investments..</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_GainLossOnInvestments1' xlink:to='lab_fil_GainLossOnInvestments1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_InterestIncome3' xlink:label='fil_InterestIncome3'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestIncome3' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest income.</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestIncome3' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The aggregate interest and fee income generated by: (1) loans the Entity has positive intent and ability to hold for the foreseeable future, or until maturity or payoff, including commercial and consumer loans, whether domestic or foreign, which may consist of: (a) industrial and agricultural; (b) real estate; and (c) real estate construction loans; (d) trade financing; (e) lease financing; (f) home equity lines-of-credit; (g) automobile and other vehicle loans; and (h) credit card and other revolving-type loans and (2) loans and leases held-for-sale which may include mortgage loans, direct financing, and sales-type leases.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InterestIncome3' xlink:to='lab_fil_InterestIncome3'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_InterestExpense1' xlink:label='fil_InterestExpense1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestExpense1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest expense {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestExpense1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Interest expense</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestExpense1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount of the cost of borrowed funds accounted for as interest expense.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InterestExpense1' xlink:to='lab_fil_InterestExpense1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PatentAndLicenseFeeFacilityWithLarsonDetailsAbstract' xlink:label='fil_PatentAndLicenseFeeFacilityWithLarsonDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PatentAndLicenseFeeFacilityWithLarsonDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Patent and License Fee Facility with Larson Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PatentAndLicenseFeeFacilityWithLarsonDetailsAbstract' xlink:to='lab_fil_PatentAndLicenseFeeFacilityWithLarsonDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_AccruedIncentiveFeeAndBonus' xlink:label='fil_AccruedIncentiveFeeAndBonus'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccruedIncentiveFeeAndBonus' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrued incentive fee and bonus</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccruedIncentiveFeeAndBonus' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Accrued incentive fee and bonus</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AccruedIncentiveFeeAndBonus' xlink:to='lab_fil_AccruedIncentiveFeeAndBonus'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_NetOfUnamortizedLoanServiceFee' xlink:label='fil_NetOfUnamortizedLoanServiceFee'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetOfUnamortizedLoanServiceFee' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net of unamortized loan service fee</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetOfUnamortizedLoanServiceFee' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Net of unamortized loan service fee</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NetOfUnamortizedLoanServiceFee' xlink:to='lab_fil_NetOfUnamortizedLoanServiceFee'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_WarrantRedemptionLiabilityDetailsAbstract' xlink:label='fil_WarrantRedemptionLiabilityDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantRedemptionLiabilityDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrant redemption liability Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantRedemptionLiabilityDetailsAbstract' xlink:to='lab_fil_WarrantRedemptionLiabilityDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_Exercised' xlink:label='fil_Exercised'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Exercised' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Exercised</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Exercised' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of non-option equity instruments exercised by participants..</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Exercised' xlink:to='lab_fil_Exercised'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_Purchases' xlink:label='fil_Purchases'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Purchases' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Purchases</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Purchases' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Purchases</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Purchases' xlink:to='lab_fil_Purchases'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_FairValueMeasurementsUsingQuotedPricesForIdenticalOrSimilarAssetsInActiveMarketsLevel2OtherInvestmentMember' xlink:label='fil_FairValueMeasurementsUsingQuotedPricesForIdenticalOrSimilarAssetsInActiveMarketsLevel2OtherInvestmentMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_FairValueMeasurementsUsingQuotedPricesForIdenticalOrSimilarAssetsInActiveMarketsLevel2OtherInvestmentMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair Value Measurements Using Quoted Prices for Identical or Similar Assets in Active Markets (Level 2) Other Investment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_FairValueMeasurementsUsingQuotedPricesForIdenticalOrSimilarAssetsInActiveMarketsLevel2OtherInvestmentMember' xlink:to='lab_fil_FairValueMeasurementsUsingQuotedPricesForIdenticalOrSimilarAssetsInActiveMarketsLevel2OtherInvestmentMember'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_WorkingCapitalNote' xlink:label='fil_WorkingCapitalNote'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WorkingCapitalNote' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Working capital note</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WorkingCapitalNote' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Working capital note</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WorkingCapitalNote' xlink:to='lab_fil_WorkingCapitalNote'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ValuationCapByTheFullyDilutedNumberOfShares' xlink:label='fil_ValuationCapByTheFullyDilutedNumberOfShares'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ValuationCapByTheFullyDilutedNumberOfShares' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Valuation cap by the fully diluted number of shares</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ValuationCapByTheFullyDilutedNumberOfShares' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Valuation cap by the fully diluted number of shares</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ValuationCapByTheFullyDilutedNumberOfShares' xlink:to='lab_fil_ValuationCapByTheFullyDilutedNumberOfShares'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_NoteBoreInterestPerAnnum' xlink:label='fil_NoteBoreInterestPerAnnum'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NoteBoreInterestPerAnnum' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note bore interest per annum</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NoteBoreInterestPerAnnum' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Note bore interest per annum</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NoteBoreInterestPerAnnum' xlink:to='lab_fil_NoteBoreInterestPerAnnum'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_MentorIntendsToVigorouslyPursueCollectionOfTheEntirePlusAllAccruedInterest' xlink:label='fil_MentorIntendsToVigorouslyPursueCollectionOfTheEntirePlusAllAccruedInterest'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_MentorIntendsToVigorouslyPursueCollectionOfTheEntirePlusAllAccruedInterest' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Mentor intends to vigorously pursue collection of the entire plus all accrued interest</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_MentorIntendsToVigorouslyPursueCollectionOfTheEntirePlusAllAccruedInterest' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Mentor intends to vigorously pursue collection of the entire plus all accrued interest</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_MentorIntendsToVigorouslyPursueCollectionOfTheEntirePlusAllAccruedInterest' xlink:to='lab_fil_MentorIntendsToVigorouslyPursueCollectionOfTheEntirePlusAllAccruedInterest'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ScheduleOfOperatingSegmentsAndCorporateUnallocatedOperatingIncomeLossToConsolidatedIncomeBeforeIncomeTaxesTableTextBlockAbstract' xlink:label='fil_ScheduleOfOperatingSegmentsAndCorporateUnallocatedOperatingIncomeLossToConsolidatedIncomeBeforeIncomeTaxesTableTextBlockAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ScheduleOfOperatingSegmentsAndCorporateUnallocatedOperatingIncomeLossToConsolidatedIncomeBeforeIncomeTaxesTableTextBlockAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of operating segments and corporate-unallocated operating income (loss) to consolidated income before income taxes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ScheduleOfOperatingSegmentsAndCorporateUnallocatedOperatingIncomeLossToConsolidatedIncomeBeforeIncomeTaxesTableTextBlockAbstract' xlink:to='lab_fil_ScheduleOfOperatingSegmentsAndCorporateUnallocatedOperatingIncomeLossToConsolidatedIncomeBeforeIncomeTaxesTableTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock' xlink:label='us-gaap_EarningsPerSharePolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EarningsPerSharePolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Basic and diluted income (loss) per common share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EarningsPerSharePolicyTextBlock' xlink:to='lab_us-gaap_EarningsPerSharePolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock' xlink:label='us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Goodwill {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Goodwill</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock' xlink:to='lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock' xlink:label='us-gaap_CashAndCashEquivalentsPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash and cash equivalents {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Cash and cash equivalents</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CashAndCashEquivalentsPolicyTextBlock' xlink:to='lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_NotePurchaseAgreementAndConsultingAgreementWithGFarmalabsLimitedTextBlock' xlink:label='fil_NotePurchaseAgreementAndConsultingAgreementWithGFarmalabsLimitedTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NotePurchaseAgreementAndConsultingAgreementWithGFarmalabsLimitedTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note purchase agreement and consulting agreement with G FarmaLabs Limited {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NotePurchaseAgreementAndConsultingAgreementWithGFarmalabsLimitedTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Note purchase agreement and consulting agreement with G FarmaLabs Limited</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NotePurchaseAgreementAndConsultingAgreementWithGFarmalabsLimitedTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Note purchase agreement and consulting agreement with G FarmaLabs Limited</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NotePurchaseAgreementAndConsultingAgreementWithGFarmalabsLimitedTextBlock' xlink:to='lab_fil_NotePurchaseAgreementAndConsultingAgreementWithGFarmalabsLimitedTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PrepaidExpensesAndOtherAssets1Abstract' xlink:label='fil_PrepaidExpensesAndOtherAssets1Abstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PrepaidExpensesAndOtherAssets1Abstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Prepaid expenses and other assets:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PrepaidExpensesAndOtherAssets1Abstract' xlink:to='lab_fil_PrepaidExpensesAndOtherAssets1Abstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ConvertibleNotesReceivableNetOfCurrentPortion' xlink:label='fil_ConvertibleNotesReceivableNetOfCurrentPortion'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertibleNotesReceivableNetOfCurrentPortion' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Convertible notes receivable, net of current portion</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertibleNotesReceivableNetOfCurrentPortion' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Net amount of the investment in a contractual right to receive money on demand or on fixed or determinable dates that is recognized as an asset in the creditor&apos;s statement of financial position. Examples include, but are not limited to, credit card receivables, notes receivable and receivables relating to lessor&apos;s rights to payments from leases other than operating leases that have been recorded as assets. Excludes trade accounts receivable with contractual maturity of one year or less and arose from the sale of goods or services.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConvertibleNotesReceivableNetOfCurrentPortion' xlink:to='lab_fil_ConvertibleNotesReceivableNetOfCurrentPortion'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate' xlink:label='dei_CurrentFiscalYearEndDate'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_CurrentFiscalYearEndDate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current Fiscal Year End Date</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_CurrentFiscalYearEndDate' xlink:to='lab_dei_CurrentFiscalYearEndDate'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_NetGainsLossesReclassifiedFromAccumulatedOtherComprehensiveIncomeToNetIncome' xlink:label='fil_NetGainsLossesReclassifiedFromAccumulatedOtherComprehensiveIncomeToNetIncome'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetGainsLossesReclassifiedFromAccumulatedOtherComprehensiveIncomeToNetIncome' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net gains (losses) reclassified from accumulated other comprehensive income to net income</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetGainsLossesReclassifiedFromAccumulatedOtherComprehensiveIncomeToNetIncome' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Net gains (losses) reclassified from accumulated other comprehensive income to net income</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NetGainsLossesReclassifiedFromAccumulatedOtherComprehensiveIncomeToNetIncome' xlink:to='lab_fil_NetGainsLossesReclassifiedFromAccumulatedOtherComprehensiveIncomeToNetIncome'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_TotalAssets3' xlink:label='fil_TotalAssets3'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalAssets3' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total assets. {2}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalAssets3' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Total assets.</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalAssets3' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalAssets3' xlink:to='lab_fil_TotalAssets3'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PropertyAdditions' xlink:label='fil_PropertyAdditions'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PropertyAdditions' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property additions</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PropertyAdditions' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PropertyAdditions' xlink:to='lab_fil_PropertyAdditions'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_MentorWasServedWithAComplaintInAnActionInTheUnitedStatesDistrictCourtForTheDistrictOfUtahInitiatedByTheWifeAndDaughterOfBhangSCorporateCounselRelatedToShares' xlink:label='fil_MentorWasServedWithAComplaintInAnActionInTheUnitedStatesDistrictCourtForTheDistrictOfUtahInitiatedByTheWifeAndDaughterOfBhangSCorporateCounselRelatedToShares'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_MentorWasServedWithAComplaintInAnActionInTheUnitedStatesDistrictCourtForTheDistrictOfUtahInitiatedByTheWifeAndDaughterOfBhangSCorporateCounselRelatedToShares' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Mentor was served with a complaint in an action in the United States District Court for the District of Utah initiated by the wife and daughter of Bhang&apos;s corporate counsel related to shares</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_MentorWasServedWithAComplaintInAnActionInTheUnitedStatesDistrictCourtForTheDistrictOfUtahInitiatedByTheWifeAndDaughterOfBhangSCorporateCounselRelatedToShares' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Mentor was served with a complaint in an action in the United States District Court for the District of Utah initiated by the wife and daughter of Bhang&apos;s corporate counsel related to shares</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_MentorWasServedWithAComplaintInAnActionInTheUnitedStatesDistrictCourtForTheDistrictOfUtahInitiatedByTheWifeAndDaughterOfBhangSCorporateCounselRelatedToShares' xlink:to='lab_fil_MentorWasServedWithAComplaintInAnActionInTheUnitedStatesDistrictCourtForTheDistrictOfUtahInitiatedByTheWifeAndDaughterOfBhangSCorporateCounselRelatedToShares'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PaidForTheDomesticLicensingRights' xlink:label='fil_PaidForTheDomesticLicensingRights'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PaidForTheDomesticLicensingRights' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Paid for the domestic licensing rights</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PaidForTheDomesticLicensingRights' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Paid for the domestic licensing rights</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PaidForTheDomesticLicensingRights' xlink:to='lab_fil_PaidForTheDomesticLicensingRights'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_SharesInAnEscrow' xlink:label='fil_SharesInAnEscrow'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_SharesInAnEscrow' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Shares in an escrow</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_SharesInAnEscrow' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Shares in an escrow</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_SharesInAnEscrow' xlink:to='lab_fil_SharesInAnEscrow'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_TotalNotesPayable' xlink:label='fil_TotalNotesPayable'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalNotesPayable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total notes payable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalNotesPayable' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalNotesPayable' xlink:to='lab_fil_TotalNotesPayable'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_SharesAuthorizedAbstract' xlink:label='fil_SharesAuthorizedAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_SharesAuthorizedAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Shares Authorized:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_SharesAuthorizedAbstract' xlink:to='lab_fil_SharesAuthorizedAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_WarrantsIssued' xlink:label='fil_WarrantsIssued'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsIssued' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrants Issued</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsIssued' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Warrants Issued</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantsIssued' xlink:to='lab_fil_WarrantsIssued'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_WeightedAverageOutstandingWarrantExercisePricePerShare' xlink:label='fil_WeightedAverageOutstandingWarrantExercisePricePerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageOutstandingWarrantExercisePricePerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted average outstanding warrant exercise price per share</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageOutstandingWarrantExercisePricePerShare' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Weighted average outstanding warrant exercise price per share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WeightedAverageOutstandingWarrantExercisePricePerShare' xlink:to='lab_fil_WeightedAverageOutstandingWarrantExercisePricePerShare'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_Sales1' xlink:label='fil_Sales1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Sales1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Sales {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Sales1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Sales</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Sales1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts..</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Sales1' xlink:to='lab_fil_Sales1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_TotalGainsOrLossesAbstract' xlink:label='fil_TotalGainsOrLossesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalGainsOrLossesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total gains or losses</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalGainsOrLossesAbstract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Balance</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalGainsOrLossesAbstract' xlink:to='lab_fil_TotalGainsOrLossesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_RequiresMonthlyPaymentsOf3505WithABalloonPaymentAtMaturity' xlink:label='fil_RequiresMonthlyPaymentsOf3505WithABalloonPaymentAtMaturity'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RequiresMonthlyPaymentsOf3505WithABalloonPaymentAtMaturity' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Requires monthly payments of $3,505 with a balloon payment at maturity</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_RequiresMonthlyPaymentsOf3505WithABalloonPaymentAtMaturity' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Requires monthly payments of $3,505 with a balloon payment at maturity</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RequiresMonthlyPaymentsOf3505WithABalloonPaymentAtMaturity' xlink:to='lab_fil_RequiresMonthlyPaymentsOf3505WithABalloonPaymentAtMaturity'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ClosingOfAFutureFinancingRoundOfAtLeast' xlink:label='fil_ClosingOfAFutureFinancingRoundOfAtLeast'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ClosingOfAFutureFinancingRoundOfAtLeast' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Closing of a future financing round of at least</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ClosingOfAFutureFinancingRoundOfAtLeast' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Closing of a future financing round of at least</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ClosingOfAFutureFinancingRoundOfAtLeast' xlink:to='lab_fil_ClosingOfAFutureFinancingRoundOfAtLeast'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_NetPropertyAndEquipment' xlink:label='fil_NetPropertyAndEquipment'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetPropertyAndEquipment' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net Property and equipment</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetPropertyAndEquipment' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NetPropertyAndEquipment' xlink:to='lab_fil_NetPropertyAndEquipment'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_LongTermPortion' xlink:label='fil_LongTermPortion'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LongTermPortion' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Long term portion</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LongTermPortion' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Long term portion</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LongTermPortion' xlink:to='lab_fil_LongTermPortion'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_AmortizedMonthlyInterestInYears' xlink:label='fil_AmortizedMonthlyInterestInYears'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AmortizedMonthlyInterestInYears' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amortized monthly interest in years</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AmortizedMonthlyInterestInYears' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amortized monthly interest in years</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AmortizedMonthlyInterestInYears' xlink:to='lab_fil_AmortizedMonthlyInterestInYears'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ReceivableAndAccruedInterestConsistsOfTheFollowingDetailsAbstract' xlink:label='fil_ReceivableAndAccruedInterestConsistsOfTheFollowingDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ReceivableAndAccruedInterestConsistsOfTheFollowingDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Receivable and accrued interest consists of the following Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ReceivableAndAccruedInterestConsistsOfTheFollowingDetailsAbstract' xlink:to='lab_fil_ReceivableAndAccruedInterestConsistsOfTheFollowingDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PrepaidHealthInsurance' xlink:label='fil_PrepaidHealthInsurance'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PrepaidHealthInsurance' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Prepaid health insurance</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PrepaidHealthInsurance' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Prepaid health insurance</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PrepaidHealthInsurance' xlink:to='lab_fil_PrepaidHealthInsurance'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_BhangPlusPreJudgmentInterestInTheAmount' xlink:label='fil_BhangPlusPreJudgmentInterestInTheAmount'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BhangPlusPreJudgmentInterestInTheAmount' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Bhang plus pre-judgment interest in the amount</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_BhangPlusPreJudgmentInterestInTheAmount' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Bhang plus pre-judgment interest in the amount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BhangPlusPreJudgmentInterestInTheAmount' xlink:to='lab_fil_BhangPlusPreJudgmentInterestInTheAmount'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_EquityAbstract1' xlink:label='fil_EquityAbstract1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_EquityAbstract1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accumulated other comprehensive income (loss) {2}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_EquityAbstract1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Accumulated other comprehensive income (loss)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_EquityAbstract1' xlink:to='lab_fil_EquityAbstract1'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock' xlink:label='us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property and equipment {2}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Property and equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NatureOfOperations' xlink:label='us-gaap_NatureOfOperations'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NatureOfOperations' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Nature of operations {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NatureOfOperations' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Nature of operations</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NatureOfOperations' xlink:to='lab_us-gaap_NatureOfOperations'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ShareholderAssumptionOfWarrantLiabilityResultingInIncreasedLiabilityToShareholder1' xlink:label='fil_ShareholderAssumptionOfWarrantLiabilityResultingInIncreasedLiabilityToShareholder1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ShareholderAssumptionOfWarrantLiabilityResultingInIncreasedLiabilityToShareholder1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Shareholder assumption of warrant liability resulting in increased liability to shareholder</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ShareholderAssumptionOfWarrantLiabilityResultingInIncreasedLiabilityToShareholder1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Shareholder purchase of shares through decrease in liability to shareholder</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ShareholderAssumptionOfWarrantLiabilityResultingInIncreasedLiabilityToShareholder1' xlink:to='lab_fil_ShareholderAssumptionOfWarrantLiabilityResultingInIncreasedLiabilityToShareholder1'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities' xlink:label='us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrued salary, retirement and benefits - related party</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities' xlink:to='lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationAndAmortization' xlink:label='us-gaap_DepreciationAndAmortization'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DepreciationAndAmortization' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Depreciation and amortization</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DepreciationAndAmortization' xlink:to='lab_us-gaap_DepreciationAndAmortization'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus' xlink:label='dei_EntityCurrentReportingStatus'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCurrentReportingStatus' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Current Reporting Status</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCurrentReportingStatus' xlink:to='lab_dei_EntityCurrentReportingStatus'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_FarmaAlsoPurchasedAnAdditionalSharesOfCompanyCommonStockForAnAdditionalPayable' xlink:label='fil_FarmaAlsoPurchasedAnAdditionalSharesOfCompanyCommonStockForAnAdditionalPayable'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_FarmaAlsoPurchasedAnAdditionalSharesOfCompanyCommonStockForAnAdditionalPayable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Farma also purchased an additional shares of Company Common Stock for an additional payable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_FarmaAlsoPurchasedAnAdditionalSharesOfCompanyCommonStockForAnAdditionalPayable' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Farma also purchased an additional shares of Company Common Stock for an additional payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_FarmaAlsoPurchasedAnAdditionalSharesOfCompanyCommonStockForAnAdditionalPayable' xlink:to='lab_fil_FarmaAlsoPurchasedAnAdditionalSharesOfCompanyCommonStockForAnAdditionalPayable'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ElectrumWithInterestPerAnnumCompoundedMonthly' xlink:label='fil_ElectrumWithInterestPerAnnumCompoundedMonthly'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ElectrumWithInterestPerAnnumCompoundedMonthly' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Electrum with interest per annum compounded monthly</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ElectrumWithInterestPerAnnumCompoundedMonthly' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Electrum with interest per annum compounded monthly</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ElectrumWithInterestPerAnnumCompoundedMonthly' xlink:to='lab_fil_ElectrumWithInterestPerAnnumCompoundedMonthly'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_SubsequentEventsDetailsAbstract' xlink:label='fil_SubsequentEventsDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_SubsequentEventsDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Subsequent events Details</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_SubsequentEventsDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Beginning balance of Marketable securities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_SubsequentEventsDetailsAbstract' xlink:to='lab_fil_SubsequentEventsDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_OperatingLoss' xlink:label='fil_OperatingLoss'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_OperatingLoss' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Operating loss</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_OperatingLoss' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The net result for the period of deducting operating expenses from operating revenues</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_OperatingLoss' xlink:to='lab_fil_OperatingLoss'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_NetSales2' xlink:label='fil_NetSales2'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetSales2' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net sales,</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetSales2' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Trash Management - Net sales</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NetSales2' xlink:to='lab_fil_NetSales2'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_BidPriceOfStockBeyondTheBookValueAtConfirmationOfBankruptcy' xlink:label='fil_BidPriceOfStockBeyondTheBookValueAtConfirmationOfBankruptcy'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BidPriceOfStockBeyondTheBookValueAtConfirmationOfBankruptcy' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Bid price of stock beyond the book value at confirmation of bankruptcy</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_BidPriceOfStockBeyondTheBookValueAtConfirmationOfBankruptcy' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Bid price of stock beyond the book value at confirmation of bankruptcy</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BidPriceOfStockBeyondTheBookValueAtConfirmationOfBankruptcy' xlink:to='lab_fil_BidPriceOfStockBeyondTheBookValueAtConfirmationOfBankruptcy'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_TotalPayments' xlink:label='fil_TotalPayments'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalPayments' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total payments</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalPayments' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total payments</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalPayments' xlink:to='lab_fil_TotalPayments'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_EquipmentLeaseExpense' xlink:label='fil_EquipmentLeaseExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_EquipmentLeaseExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Equipment lease expense</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_EquipmentLeaseExpense' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The cash outflow for payments to acquire rented equipment which is recorded as an asset.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_EquipmentLeaseExpense' xlink:to='lab_fil_EquipmentLeaseExpense'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_NumberOfAuthorizedSharesOfCommonStockAfterReduced' xlink:label='fil_NumberOfAuthorizedSharesOfCommonStockAfterReduced'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NumberOfAuthorizedSharesOfCommonStockAfterReduced' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Number of authorized shares of Common Stock after reduced</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NumberOfAuthorizedSharesOfCommonStockAfterReduced' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of authorized shares of Common Stock after reduced</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NumberOfAuthorizedSharesOfCommonStockAfterReduced' xlink:to='lab_fil_NumberOfAuthorizedSharesOfCommonStockAfterReduced'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_Outstanding2' xlink:label='fil_Outstanding2'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Outstanding2' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Outstanding {2}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Outstanding2' xlink:role='http://www.xbrl.org/2003/role/periodStartLabel' xml:lang='en-US'>Outstanding</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Outstanding2' xlink:role='http://www.xbrl.org/2003/role/periodEndLabel' xml:lang='en-US'>Outstanding</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Outstanding2' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of shares issued which are neither cancelled nor held in the treasury.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Outstanding2' xlink:to='lab_fil_Outstanding2'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ExercisePricesDetailsAbstract' xlink:label='fil_ExercisePricesDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePricesDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Exercise Prices Details:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ExercisePricesDetailsAbstract' xlink:to='lab_fil_ExercisePricesDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_NotesReceivableFromGFarmaConsistsOfTheFollowingAbstract' xlink:label='fil_NotesReceivableFromGFarmaConsistsOfTheFollowingAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NotesReceivableFromGFarmaConsistsOfTheFollowingAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Notes receivable from G Farma consists of the following</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NotesReceivableFromGFarmaConsistsOfTheFollowingAbstract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Net Property and equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NotesReceivableFromGFarmaConsistsOfTheFollowingAbstract' xlink:to='lab_fil_NotesReceivableFromGFarmaConsistsOfTheFollowingAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ConvertibleNotesReceivableParentheticalsDetailsAbstract' xlink:label='fil_ConvertibleNotesReceivableParentheticalsDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertibleNotesReceivableParentheticalsDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Convertible notes receivable Parentheticals Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConvertibleNotesReceivableParentheticalsDetailsAbstract' xlink:to='lab_fil_ConvertibleNotesReceivableParentheticalsDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_NeucourtIncConvertibleNoteReceivableIncludingAccruedInterestOf489And181AtMarch312017' xlink:label='fil_NeucourtIncConvertibleNoteReceivableIncludingAccruedInterestOf489And181AtMarch312017'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NeucourtIncConvertibleNoteReceivableIncludingAccruedInterestOf489And181AtMarch312017' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>NeuCourt, Inc. convertible note receivable including accrued interest of $489 and $181 at March 31, 2017</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NeucourtIncConvertibleNoteReceivableIncludingAccruedInterestOf489And181AtMarch312017' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>NeuCourt, Inc. convertible note receivable including accrued interest of $489 and $181 at March 31, 2017</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NeucourtIncConvertibleNoteReceivableIncludingAccruedInterestOf489And181AtMarch312017' xlink:to='lab_fil_NeucourtIncConvertibleNoteReceivableIncludingAccruedInterestOf489And181AtMarch312017'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ConvertibleNotesReceivableDetailsAbstract' xlink:label='fil_ConvertibleNotesReceivableDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertibleNotesReceivableDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Convertible notes receivable Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConvertibleNotesReceivableDetailsAbstract' xlink:to='lab_fil_ConvertibleNotesReceivableDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_CompanyWillReceiveAnInvestmentInAnAccountReceivableTotal' xlink:label='fil_CompanyWillReceiveAnInvestmentInAnAccountReceivableTotal'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyWillReceiveAnInvestmentInAnAccountReceivableTotal' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company will receive an investment in an account receivable total</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyWillReceiveAnInvestmentInAnAccountReceivableTotal' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company will receive an investment in an account receivable total</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanyWillReceiveAnInvestmentInAnAccountReceivableTotal' xlink:to='lab_fil_CompanyWillReceiveAnInvestmentInAnAccountReceivableTotal'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_InterestOnNoteIncreasedRate' xlink:label='fil_InterestOnNoteIncreasedRate'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestOnNoteIncreasedRate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest on note (Increased rate)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestOnNoteIncreasedRate' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Interest on note (Increased rate)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InterestOnNoteIncreasedRate' xlink:to='lab_fil_InterestOnNoteIncreasedRate'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_NatureOfOperationsDetailsAbstract' xlink:label='fil_NatureOfOperationsDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NatureOfOperationsDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Nature of operations Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NatureOfOperationsDetailsAbstract' xlink:to='lab_fil_NatureOfOperationsDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock' xlink:label='us-gaap_ScheduleOfDebtTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfDebtTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Long Term Debt (Tables) {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfDebtTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Schedule of Long Term Debt (Tables)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfDebtTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfDebtTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_AccruedSalaryAccruedRetirementAndRelatedPartyIncentiveFeeTextBlock' xlink:label='fil_AccruedSalaryAccruedRetirementAndRelatedPartyIncentiveFeeTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccruedSalaryAccruedRetirementAndRelatedPartyIncentiveFeeTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrued salary, accrued retirement and incentive fee - related party {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccruedSalaryAccruedRetirementAndRelatedPartyIncentiveFeeTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Accrued salary, accrued retirement and incentive fee - related party</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccruedSalaryAccruedRetirementAndRelatedPartyIncentiveFeeTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Entire disclosure for accrued retirement and related party incentive fee</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AccruedSalaryAccruedRetirementAndRelatedPartyIncentiveFeeTextBlock' xlink:to='lab_fil_AccruedSalaryAccruedRetirementAndRelatedPartyIncentiveFeeTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock' xlink:label='us-gaap_StockholdersEquityNoteDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stockholders&apos; equity</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockholdersEquityNoteDisclosureTextBlock' xlink:to='lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_SummaryOfSignificantAccountingPoliciesAbstract' xlink:label='fil_SummaryOfSignificantAccountingPoliciesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_SummaryOfSignificantAccountingPoliciesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Summary of significant accounting policies</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_SummaryOfSignificantAccountingPoliciesAbstract' xlink:to='lab_fil_SummaryOfSignificantAccountingPoliciesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract' xlink:label='us-gaap_SupplementalCashFlowInformationAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SupplementalCashFlowInformationAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>SUPPLEMENTARY INFORMATION:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SupplementalCashFlowInformationAbstract' xlink:to='lab_us-gaap_SupplementalCashFlowInformationAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_BorrowingPaymentOnLineOfCredit' xlink:label='fil_BorrowingPaymentOnLineOfCredit'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BorrowingPaymentOnLineOfCredit' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Borrowing on line of credit</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_BorrowingPaymentOnLineOfCredit' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Borrowing (payment) on line of credit</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BorrowingPaymentOnLineOfCredit' xlink:to='lab_fil_BorrowingPaymentOnLineOfCredit'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments' xlink:label='us-gaap_GainLossOnSaleOfInvestments'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_GainLossOnSaleOfInvestments' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Investment loss</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_GainLossOnSaleOfInvestments' xlink:to='lab_us-gaap_GainLossOnSaleOfInvestments'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_NetLossesReclassifiedFromAociToNetIncome' xlink:label='fil_NetLossesReclassifiedFromAociToNetIncome'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetLossesReclassifiedFromAociToNetIncome' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net losses reclassified from AOCI to net income.</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetLossesReclassifiedFromAociToNetIncome' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Net losses reclassified from AOCI to net income.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NetLossesReclassifiedFromAociToNetIncome' xlink:to='lab_fil_NetLossesReclassifiedFromAociToNetIncome'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract' xlink:label='us-gaap_EarningsPerShareAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EarningsPerShareAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Basic and diluted net income (loss) per Mentor common share:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EarningsPerShareAbstract' xlink:to='lab_us-gaap_EarningsPerShareAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherOperatingIncome' xlink:label='us-gaap_OtherOperatingIncome'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherOperatingIncome' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other income (expense)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherOperatingIncome' xlink:to='lab_us-gaap_OtherOperatingIncome'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding' xlink:label='us-gaap_PreferredStockSharesOutstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PreferredStockSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred stock, Shares Outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PreferredStockSharesOutstanding' xlink:to='lab_us-gaap_PreferredStockSharesOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinorityInterest' xlink:label='us-gaap_MinorityInterest'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_MinorityInterest' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Non-controlling interest</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_MinorityInterest' xlink:to='lab_us-gaap_MinorityInterest'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract' xlink:label='us-gaap_PropertyPlantAndEquipmentNetAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentNetAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property and equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentNetAbstract' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentNetAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ElectrumToAllowInterestOnlyPaymentsToContinueUntilMentorDetermines' xlink:label='fil_ElectrumToAllowInterestOnlyPaymentsToContinueUntilMentorDetermines'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ElectrumToAllowInterestOnlyPaymentsToContinueUntilMentorDetermines' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Electrum to allow interest only payments to continue until Mentor determines</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ElectrumToAllowInterestOnlyPaymentsToContinueUntilMentorDetermines' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Electrum to allow interest only payments to continue until Mentor determines</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ElectrumToAllowInterestOnlyPaymentsToContinueUntilMentorDetermines' xlink:to='lab_fil_ElectrumToAllowInterestOnlyPaymentsToContinueUntilMentorDetermines'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_IncomeBeforeIncomeTaxes' xlink:label='fil_IncomeBeforeIncomeTaxes'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncomeBeforeIncomeTaxes' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Income before income taxes</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncomeBeforeIncomeTaxes' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Income before income taxes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IncomeBeforeIncomeTaxes' xlink:to='lab_fil_IncomeBeforeIncomeTaxes'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_DepreciationAndAmortization4' xlink:label='fil_DepreciationAndAmortization4'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DepreciationAndAmortization4' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Depreciation and amortization;</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_DepreciationAndAmortization4' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DepreciationAndAmortization4' xlink:to='lab_fil_DepreciationAndAmortization4'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_DepreciationAndAmortization2' xlink:label='fil_DepreciationAndAmortization2'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DepreciationAndAmortization2' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Depreciation and amortization,</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_DepreciationAndAmortization2' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DepreciationAndAmortization2' xlink:to='lab_fil_DepreciationAndAmortization2'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_TheJudgmentAccruesInterestAtTheRate' xlink:label='fil_TheJudgmentAccruesInterestAtTheRate'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TheJudgmentAccruesInterestAtTheRate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>The judgment accrues interest at the rate</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TheJudgmentAccruesInterestAtTheRate' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The judgment accrues interest at the rate</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TheJudgmentAccruesInterestAtTheRate' xlink:to='lab_fil_TheJudgmentAccruesInterestAtTheRate'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_AccruedSalaryAccruedRetirementAndIncentiveFeeRelatedPartyAbstract' xlink:label='fil_AccruedSalaryAccruedRetirementAndIncentiveFeeRelatedPartyAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccruedSalaryAccruedRetirementAndIncentiveFeeRelatedPartyAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrued salary, accrued retirement and incentive fee - related party {2}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccruedSalaryAccruedRetirementAndIncentiveFeeRelatedPartyAbstract' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Accrued salary, accrued retirement and incentive fee - related party</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AccruedSalaryAccruedRetirementAndIncentiveFeeRelatedPartyAbstract' xlink:to='lab_fil_AccruedSalaryAccruedRetirementAndIncentiveFeeRelatedPartyAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_LongTermDebtParentheticalsDetails1Abstract' xlink:label='fil_LongTermDebtParentheticalsDetails1Abstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LongTermDebtParentheticalsDetails1Abstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Long term debt (Parentheticals) Details</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LongTermDebtParentheticalsDetails1Abstract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Monthly principal and interest payments on auto loans through Hyundai Motor Finance</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LongTermDebtParentheticalsDetails1Abstract' xlink:to='lab_fil_LongTermDebtParentheticalsDetails1Abstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_WciLeasesVehicleVehicleLeaseExpenseIncludedInCostOfSales' xlink:label='fil_WciLeasesVehicleVehicleLeaseExpenseIncludedInCostOfSales'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WciLeasesVehicleVehicleLeaseExpenseIncludedInCostOfSales' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>WCI leases vehicle - vehicle lease expense included in cost of sales</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WciLeasesVehicleVehicleLeaseExpenseIncludedInCostOfSales' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WciLeasesVehicleVehicleLeaseExpenseIncludedInCostOfSales' xlink:to='lab_fil_WciLeasesVehicleVehicleLeaseExpenseIncludedInCostOfSales'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_OutstandingEFGAndHWarrants' xlink:label='fil_OutstandingEFGAndHWarrants'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_OutstandingEFGAndHWarrants' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Outstanding E, F, G and H Warrants</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_OutstandingEFGAndHWarrants' xlink:role='http://www.xbrl.org/2003/role/periodStartLabel' xml:lang='en-US'>Outstanding E, F, G and H Warrants</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_OutstandingEFGAndHWarrants' xlink:role='http://www.xbrl.org/2003/role/periodEndLabel' xml:lang='en-US'>Outstanding E, F, G and H Warrants</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_OutstandingEFGAndHWarrants' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of warrants or rights outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_OutstandingEFGAndHWarrants' xlink:to='lab_fil_OutstandingEFGAndHWarrants'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_TotalWarrantsWereExercised' xlink:label='fil_TotalWarrantsWereExercised'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalWarrantsWereExercised' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total warrants were exercised</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalWarrantsWereExercised' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total warrants were exercised</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalWarrantsWereExercised' xlink:to='lab_fil_TotalWarrantsWereExercised'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_Sales' xlink:label='fil_Sales'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Sales' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Sales</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Sales' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Sales' xlink:to='lab_fil_Sales'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_Balance' xlink:label='fil_Balance'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Balance' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Balance</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Balance' xlink:role='http://www.xbrl.org/2003/role/periodStartLabel' xml:lang='en-US'>Balance</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Balance' xlink:role='http://www.xbrl.org/2003/role/periodEndLabel' xml:lang='en-US'>Balance</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Balance' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Balance, as of the indicated date.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Balance' xlink:to='lab_fil_Balance'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_FirstPromissoryNoteInTheAmountIsForThePurchaseOfRealEstate' xlink:label='fil_FirstPromissoryNoteInTheAmountIsForThePurchaseOfRealEstate'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_FirstPromissoryNoteInTheAmountIsForThePurchaseOfRealEstate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>First promissory note in the amount is for the purchase of real estate</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_FirstPromissoryNoteInTheAmountIsForThePurchaseOfRealEstate' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>First promissory note in the amount is for the purchase of real estate</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_FirstPromissoryNoteInTheAmountIsForThePurchaseOfRealEstate' xlink:to='lab_fil_FirstPromissoryNoteInTheAmountIsForThePurchaseOfRealEstate'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_CompanySharesExchangedInTheTransactionResultingInADiscountFromTheFaceValueOfTheAccountReceivable1' xlink:label='fil_CompanySharesExchangedInTheTransactionResultingInADiscountFromTheFaceValueOfTheAccountReceivable1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanySharesExchangedInTheTransactionResultingInADiscountFromTheFaceValueOfTheAccountReceivable1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company shares exchanged in the transaction, resulting in a discount from the face value of the account receivable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanySharesExchangedInTheTransactionResultingInADiscountFromTheFaceValueOfTheAccountReceivable1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company shares exchanged in the transaction, resulting in a discount from the face value of the account receivable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanySharesExchangedInTheTransactionResultingInADiscountFromTheFaceValueOfTheAccountReceivable1' xlink:to='lab_fil_CompanySharesExchangedInTheTransactionResultingInADiscountFromTheFaceValueOfTheAccountReceivable1'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense' xlink:label='us-gaap_MarketingAndAdvertisingExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_MarketingAndAdvertisingExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Advertising and promotion costs</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_MarketingAndAdvertisingExpense' xlink:to='lab_us-gaap_MarketingAndAdvertisingExpense'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_AdvertisingAndPromotionDetailsAbstract' xlink:label='fil_AdvertisingAndPromotionDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AdvertisingAndPromotionDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Advertising and promotion details</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AdvertisingAndPromotionDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Goodwill was recorded on the acquisition of CAST</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AdvertisingAndPromotionDetailsAbstract' xlink:to='lab_fil_AdvertisingAndPromotionDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_CompanyReceivedAnInvestmentInAccountReceivableWithInstallmentPayments' xlink:label='fil_CompanyReceivedAnInvestmentInAccountReceivableWithInstallmentPayments'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyReceivedAnInvestmentInAccountReceivableWithInstallmentPayments' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company received an investment in account receivable with installment payments</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyReceivedAnInvestmentInAccountReceivableWithInstallmentPayments' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company received an investment in account receivable with installment payments</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanyReceivedAnInvestmentInAccountReceivableWithInstallmentPayments' xlink:to='lab_fil_CompanyReceivedAnInvestmentInAccountReceivableWithInstallmentPayments'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent' xlink:label='us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Allowances for doubtful accounts</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent' xlink:to='lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock' xlink:label='us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Hierarchy of Assets (Tables)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock' xlink:to='lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock' xlink:label='us-gaap_ScheduleOfDebtInstrumentsTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Notes receivable from G Farma consists</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfDebtInstrumentsTextBlock' xlink:to='lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock' xlink:label='us-gaap_PropertyPlantAndEquipmentTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Property and Equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentTextBlock' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PropertyPlantAndEquipmentAbstract1' xlink:label='fil_PropertyPlantAndEquipmentAbstract1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PropertyPlantAndEquipmentAbstract1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Property and Equipment:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PropertyPlantAndEquipmentAbstract1' xlink:to='lab_fil_PropertyPlantAndEquipmentAbstract1'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock' xlink:label='us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Recent Accounting Standards</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock' xlink:to='lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates' xlink:label='us-gaap_UseOfEstimates'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_UseOfEstimates' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Use of estimates</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_UseOfEstimates' xlink:to='lab_us-gaap_UseOfEstimates'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_CommonStockWarrantsTextBlock' xlink:label='fil_CommonStockWarrantsTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonStockWarrantsTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common stock warrants</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonStockWarrantsTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The entire disclosure is about the Company&apos;s Common stock warrants</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CommonStockWarrantsTextBlock' xlink:to='lab_fil_CommonStockWarrantsTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract' xlink:label='us-gaap_NoncashInvestingAndFinancingItemsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>NON-CASH INVESTING AND FINANCING TRANSACTION:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NoncashInvestingAndFinancingItemsAbstract' xlink:to='lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesPaidNet' xlink:label='us-gaap_IncomeTaxesPaidNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeTaxesPaidNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash paid for income taxes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeTaxesPaidNet' xlink:to='lab_us-gaap_IncomeTaxesPaidNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt' xlink:label='us-gaap_ProceedsFromConvertibleDebt'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProceedsFromConvertibleDebt' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Sale of convertible security</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ProceedsFromConvertibleDebt' xlink:to='lab_us-gaap_ProceedsFromConvertibleDebt'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities' xlink:label='us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Proceeds from securities sold</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities' xlink:to='lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold' xlink:label='us-gaap_CostOfGoodsAndServicesSold'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CostOfGoodsAndServicesSold' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cost of sales</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CostOfGoodsAndServicesSold' xlink:to='lab_us-gaap_CostOfGoodsAndServicesSold'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies' xlink:label='us-gaap_CommitmentsAndContingencies'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommitmentsAndContingencies' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Commitments and Contingencies</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommitmentsAndContingencies' xlink:to='lab_us-gaap_CommitmentsAndContingencies'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermInvestments' xlink:label='us-gaap_LongTermInvestments'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LongTermInvestments' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Long term investments</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LongTermInvestments' xlink:to='lab_us-gaap_LongTermInvestments'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_NotesReceivableNetOfCurrentPortion' xlink:label='fil_NotesReceivableNetOfCurrentPortion'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NotesReceivableNetOfCurrentPortion' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Notes receivable, net of current portion</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NotesReceivableNetOfCurrentPortion' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Net amount of the investment in a contractual right to receive money on demand or on fixed or determinable dates that is recognized as an asset in the creditor&apos;s statement of financial position. Examples include, but are not limited to, credit card receivables, notes receivable and receivables relating to lessor&apos;s rights to payments from leases other than operating leases that have been recorded as assets. Excludes trade accounts receivable with contractual maturity of one year or less and arose from the sale of goods or services.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NotesReceivableNetOfCurrentPortion' xlink:to='lab_fil_NotesReceivableNetOfCurrentPortion'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsAbstract' xlink:label='us-gaap_OtherAssetsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherAssetsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherAssetsAbstract' xlink:to='lab_us-gaap_OtherAssetsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PaymentsForServicesProvidedUnderTheConsultingAgreementWillIncreaseFrom1400PerMonthTo' xlink:label='fil_PaymentsForServicesProvidedUnderTheConsultingAgreementWillIncreaseFrom1400PerMonthTo'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PaymentsForServicesProvidedUnderTheConsultingAgreementWillIncreaseFrom1400PerMonthTo' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Payments for services provided under the Consulting Agreement will increase from 1,400 per month to</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PaymentsForServicesProvidedUnderTheConsultingAgreementWillIncreaseFrom1400PerMonthTo' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Payments for services provided under the Consulting Agreement will increase from 1,400 per month to</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PaymentsForServicesProvidedUnderTheConsultingAgreementWillIncreaseFrom1400PerMonthTo' xlink:to='lab_fil_PaymentsForServicesProvidedUnderTheConsultingAgreementWillIncreaseFrom1400PerMonthTo'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_CompanyInvestedAnAdditionalInElectrumByPurchaseOfASecondPromissoryNote' xlink:label='fil_CompanyInvestedAnAdditionalInElectrumByPurchaseOfASecondPromissoryNote'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyInvestedAnAdditionalInElectrumByPurchaseOfASecondPromissoryNote' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company invested an additional in Electrum by purchase of a second promissory note</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyInvestedAnAdditionalInElectrumByPurchaseOfASecondPromissoryNote' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company invested an additional in Electrum by purchase of a second promissory note</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanyInvestedAnAdditionalInElectrumByPurchaseOfASecondPromissoryNote' xlink:to='lab_fil_CompanyInvestedAnAdditionalInElectrumByPurchaseOfASecondPromissoryNote'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_EndingBalance1' xlink:label='fil_EndingBalance1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_EndingBalance1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Ending balance</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_EndingBalance1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Ending balance</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_EndingBalance1' xlink:to='lab_fil_EndingBalance1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_LessTaxTaxBenefit' xlink:label='fil_LessTaxTaxBenefit'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LessTaxTaxBenefit' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Less: Tax (tax benefit)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LessTaxTaxBenefit' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LessTaxTaxBenefit' xlink:to='lab_fil_LessTaxTaxBenefit'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_IncomeBeforeTaxes3' xlink:label='fil_IncomeBeforeTaxes3'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncomeBeforeTaxes3' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Income before taxes {3}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncomeBeforeTaxes3' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Income before taxes</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncomeBeforeTaxes3' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Income before taxes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IncomeBeforeTaxes3' xlink:to='lab_fil_IncomeBeforeTaxes3'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_MentorFiledSuitAgainstBhangAndItsOwnersInTheUnitedStatesDistrictCourtForTheNorthernDistrictOfCaliforniaForRescissionOfTheFebruary282014CoOperativeFundingAgreementWithBhangSeekingReturnOfTheInvestment' xlink:label='fil_MentorFiledSuitAgainstBhangAndItsOwnersInTheUnitedStatesDistrictCourtForTheNorthernDistrictOfCaliforniaForRescissionOfTheFebruary282014CoOperativeFundingAgreementWithBhangSeekingReturnOfTheInvestment'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_MentorFiledSuitAgainstBhangAndItsOwnersInTheUnitedStatesDistrictCourtForTheNorthernDistrictOfCaliforniaForRescissionOfTheFebruary282014CoOperativeFundingAgreementWithBhangSeekingReturnOfTheInvestment' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Mentor filed suit against Bhang and its owners in the United States District Court for the Northern District of California for co-operative funding agreement with Bhang, seeking return of the investment</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_MentorFiledSuitAgainstBhangAndItsOwnersInTheUnitedStatesDistrictCourtForTheNorthernDistrictOfCaliforniaForRescissionOfTheFebruary282014CoOperativeFundingAgreementWithBhangSeekingReturnOfTheInvestment' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Mentor filed suit against Bhang and its owners in the United States District Court for the Northern District of California for rescission of the February 28, 2014 co-operative funding agreement with Bhang, seeking return of the investment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_MentorFiledSuitAgainstBhangAndItsOwnersInTheUnitedStatesDistrictCourtForTheNorthernDistrictOfCaliforniaForRescissionOfTheFebruary282014CoOperativeFundingAgreementWithBhangSeekingReturnOfTheInvestment' xlink:to='lab_fil_MentorFiledSuitAgainstBhangAndItsOwnersInTheUnitedStatesDistrictCourtForTheNorthernDistrictOfCaliforniaForRescissionOfTheFebruary282014CoOperativeFundingAgreementWithBhangSeekingReturnOfTheInvestment'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_N100IncreaseInStockPriceUpToAMaximumPerShare' xlink:label='fil_N100IncreaseInStockPriceUpToAMaximumPerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_N100IncreaseInStockPriceUpToAMaximumPerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>1.00 Increase in stock price up to a maximum per share</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_N100IncreaseInStockPriceUpToAMaximumPerShare' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>1.00 Increase in stock price up to a maximum per share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_N100IncreaseInStockPriceUpToAMaximumPerShare' xlink:to='lab_fil_N100IncreaseInStockPriceUpToAMaximumPerShare'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_FutureMinimumLeasePayments2018' xlink:label='fil_FutureMinimumLeasePayments2018'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_FutureMinimumLeasePayments2018' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Future minimum lease payments 2018</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_FutureMinimumLeasePayments2018' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Future minimum lease payments 2018</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_FutureMinimumLeasePayments2018' xlink:to='lab_fil_FutureMinimumLeasePayments2018'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_BDTotalWarrantsMember' xlink:label='fil_BDTotalWarrantsMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BDTotalWarrantsMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>B,D Total Warrants</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BDTotalWarrantsMember' xlink:to='lab_fil_BDTotalWarrantsMember'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_GFarmaPurchasedAnAdditionalSharesOfTheCompanySCommonStockAtAPricePerShare' xlink:label='fil_GFarmaPurchasedAnAdditionalSharesOfTheCompanySCommonStockAtAPricePerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_GFarmaPurchasedAnAdditionalSharesOfTheCompanySCommonStockAtAPricePerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>G Farma purchased an additional shares of the Company&apos;s Common Stock at a price per share</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_GFarmaPurchasedAnAdditionalSharesOfTheCompanySCommonStockAtAPricePerShare' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>G Farma purchased an additional shares of the Company&apos;s Common Stock at a price per share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_GFarmaPurchasedAnAdditionalSharesOfTheCompanySCommonStockAtAPricePerShare' xlink:to='lab_fil_GFarmaPurchasedAnAdditionalSharesOfTheCompanySCommonStockAtAPricePerShare'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ConsultingFeeIsIncreasedByAddendumIi' xlink:label='fil_ConsultingFeeIsIncreasedByAddendumIi'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConsultingFeeIsIncreasedByAddendumIi' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Consulting fee is increased by Addendum II</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConsultingFeeIsIncreasedByAddendumIi' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Consulting fee is increased by Addendum II</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConsultingFeeIsIncreasedByAddendumIi' xlink:to='lab_fil_ConsultingFeeIsIncreasedByAddendumIi'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_TotalConvertibleNotesReceivable' xlink:label='fil_TotalConvertibleNotesReceivable'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalConvertibleNotesReceivable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total convertible notes receivable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalConvertibleNotesReceivable' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total convertible notes receivable.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalConvertibleNotesReceivable' xlink:to='lab_fil_TotalConvertibleNotesReceivable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FurnitureAndFixturesGross' xlink:label='us-gaap_FurnitureAndFixturesGross'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FurnitureAndFixturesGross' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Furniture and fixtures</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FurnitureAndFixturesGross' xlink:to='lab_us-gaap_FurnitureAndFixturesGross'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_UnamortizedDiscount' xlink:label='fil_UnamortizedDiscount'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_UnamortizedDiscount' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Unamortized discount</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_UnamortizedDiscount' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Unamortized discount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_UnamortizedDiscount' xlink:to='lab_fil_UnamortizedDiscount'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PrepaidExpensesAndOtherAssetsDetailsAbstract' xlink:label='fil_PrepaidExpensesAndOtherAssetsDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PrepaidExpensesAndOtherAssetsDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Prepaid expenses and other assets Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PrepaidExpensesAndOtherAssetsDetailsAbstract' xlink:to='lab_fil_PrepaidExpensesAndOtherAssetsDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PotentiallyDilutiveSharesOutstanding' xlink:label='fil_PotentiallyDilutiveSharesOutstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PotentiallyDilutiveSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Potentially dilutive shares outstanding</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PotentiallyDilutiveSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Potentially dilutive shares outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PotentiallyDilutiveSharesOutstanding' xlink:to='lab_fil_PotentiallyDilutiveSharesOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_AccountingPoliciesAbstract1' xlink:label='fil_AccountingPoliciesAbstract1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccountingPoliciesAbstract1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounting Policies:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AccountingPoliciesAbstract1' xlink:to='lab_fil_AccountingPoliciesAbstract1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_AccumulatedOtherComprehensiveIncomeLossAbstract' xlink:label='fil_AccumulatedOtherComprehensiveIncomeLossAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccumulatedOtherComprehensiveIncomeLossAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accumulated other comprehensive income (loss)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AccumulatedOtherComprehensiveIncomeLossAbstract' xlink:to='lab_fil_AccumulatedOtherComprehensiveIncomeLossAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ConvertibleNoteReceivableTextBlockAbstract' xlink:label='fil_ConvertibleNoteReceivableTextBlockAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertibleNoteReceivableTextBlockAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Convertible note receivable Text Block:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConvertibleNoteReceivableTextBlockAbstract' xlink:to='lab_fil_ConvertibleNoteReceivableTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium' xlink:label='us-gaap_AmortizationOfDebtDiscountPremium'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AmortizationOfDebtDiscountPremium' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amortization of discount on investment in account receivable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AmortizationOfDebtDiscountPremium' xlink:to='lab_us-gaap_AmortizationOfDebtDiscountPremium'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_BadDebtExpense' xlink:label='fil_BadDebtExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BadDebtExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Bad debt expense</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_BadDebtExpense' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Bad debt expense</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BadDebtExpense' xlink:to='lab_fil_BadDebtExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued' xlink:label='us-gaap_CommonStockSharesIssued'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockSharesIssued' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common Stock, Shares Issued</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockSharesIssued' xlink:to='lab_us-gaap_CommonStockSharesIssued'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockTransactionsParentheticalDisclosuresAbstract' xlink:label='us-gaap_StockTransactionsParentheticalDisclosuresAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockTransactionsParentheticalDisclosuresAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Parentheticals</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockTransactionsParentheticalDisclosuresAbstract' xlink:to='lab_us-gaap_StockTransactionsParentheticalDisclosuresAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue' xlink:label='us-gaap_CommonStockValue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockValue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common stock, $0.0001 par value, 75,000,000 shares authorized; 22,561,951 and 20,980,510 shares issued and outstanding at March 31, 2017 and December 31, 2016</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockValue' xlink:to='lab_us-gaap_CommonStockValue'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey' xlink:label='dei_EntityCentralIndexKey'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCentralIndexKey' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Central Index Key</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCentralIndexKey' xlink:to='lab_dei_EntityCentralIndexKey'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate' xlink:label='dei_DocumentPeriodEndDate'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentPeriodEndDate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document Period End Date</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentPeriodEndDate' xlink:to='lab_dei_DocumentPeriodEndDate'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType' xlink:label='dei_DocumentType'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentType' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document Type</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentType' xlink:to='lab_dei_DocumentType'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_DocumentAndEntityInformationAbstract' xlink:label='fil_DocumentAndEntityInformationAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DocumentAndEntityInformationAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document and Entity Information:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='lab_fil_DocumentAndEntityInformationAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain' xlink:label='us-gaap_EquityComponentDomain'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EquityComponentDomain' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Equity Component [Domain]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EquityComponentDomain' xlink:to='lab_us-gaap_EquityComponentDomain'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_LossOnDisposalOfInvestorWebcastAssetsAndLiabilities2' xlink:label='fil_LossOnDisposalOfInvestorWebcastAssetsAndLiabilities2'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LossOnDisposalOfInvestorWebcastAssetsAndLiabilities2' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Loss on disposal of Investor Webcast assets and liabilities {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LossOnDisposalOfInvestorWebcastAssetsAndLiabilities2' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Loss on disposal of Investor Webcast assets and liabilities</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LossOnDisposalOfInvestorWebcastAssetsAndLiabilities2' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Loss on disposal of Investor Webcast assets and liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LossOnDisposalOfInvestorWebcastAssetsAndLiabilities2' xlink:to='lab_fil_LossOnDisposalOfInvestorWebcastAssetsAndLiabilities2'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_InterestIncome4' xlink:label='fil_InterestIncome4'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestIncome4' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest income;</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestIncome4' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The aggregate interest and fee income generated by: (1) loans the Entity has positive intent and ability to hold for the foreseeable future, or until maturity or payoff, including commercial and consumer loans, whether domestic or foreign, which may consist of: (a) industrial and agricultural; (b) real estate; and (c) real estate construction loans; (d) trade financing; (e) lease financing; (f) home equity lines-of-credit; (g) automobile and other vehicle loans; and (h) credit card and other revolving-type loans and (2) loans and leases held-for-sale which may include mortgage loans, direct financing, and sales-type leases.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InterestIncome4' xlink:to='lab_fil_InterestIncome4'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_InterestExpense3' xlink:label='fil_InterestExpense3'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestExpense3' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest expense.</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestExpense3' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount of the cost of borrowed funds accounted for as interest expense.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InterestExpense3' xlink:to='lab_fil_InterestExpense3'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_AccruedRetirementAndOtherBenefits' xlink:label='fil_AccruedRetirementAndOtherBenefits'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccruedRetirementAndOtherBenefits' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrued retirement and other benefits</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccruedRetirementAndOtherBenefits' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The amount of pension and other (such as medical, dental and life insurance) postretirement benefit costs recognized during the period for (1) defined benefit plans (periodic benefit costs include the following components: service cost, interest cost, expected return on plan assets, gain (loss) on assets, prior service cost or credit, transition asset or obligation, and gain (loss) due to settlements or curtailments) and for (2) defined contribution plans (to the extent that a plan&apos;s defined contributions to an individual&apos;s account are to be made for periods in which that individual renders services, the net cost for a period is the contribution called for in that period; if a plan calls for contributions for periods after an individual retires or terminates, the estimated cost is accrued during the employee&apos;s service period).</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AccruedRetirementAndOtherBenefits' xlink:to='lab_fil_AccruedRetirementAndOtherBenefits'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_WciEnteredIntoACommercialCreditAgreement' xlink:label='fil_WciEnteredIntoACommercialCreditAgreement'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WciEnteredIntoACommercialCreditAgreement' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>WCI entered into a commercial credit agreement</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WciEnteredIntoACommercialCreditAgreement' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>WCI entered into a commercial credit agreement</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WciEnteredIntoACommercialCreditAgreement' xlink:to='lab_fil_WciEnteredIntoACommercialCreditAgreement'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_AuthorizedSharesOfCommonStockParValue' xlink:label='fil_AuthorizedSharesOfCommonStockParValue'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AuthorizedSharesOfCommonStockParValue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Authorized shares of common stock par value</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AuthorizedSharesOfCommonStockParValue' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Authorized shares of common stock par value</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AuthorizedSharesOfCommonStockParValue' xlink:to='lab_fil_AuthorizedSharesOfCommonStockParValue'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PrepaidWarrantLiability' xlink:label='fil_PrepaidWarrantLiability'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PrepaidWarrantLiability' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Prepaid warrant liability</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PrepaidWarrantLiability' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Prepaid warrant liability</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PrepaidWarrantLiability' xlink:to='lab_fil_PrepaidWarrantLiability'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_Exercised1' xlink:label='fil_Exercised1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Exercised1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Exercised {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Exercised1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Exercised</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Exercised1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of non-option equity instruments exercised by participants..</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Exercised1' xlink:to='lab_fil_Exercised1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_Purchases1' xlink:label='fil_Purchases1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Purchases1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Purchases {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Purchases1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Purchases</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Purchases1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Purchases</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Purchases1' xlink:to='lab_fil_Purchases1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_FairValueMeasurementsUsingSignificantUnobservableInputsLevel3EquityOptionsMember' xlink:label='fil_FairValueMeasurementsUsingSignificantUnobservableInputsLevel3EquityOptionsMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_FairValueMeasurementsUsingSignificantUnobservableInputsLevel3EquityOptionsMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair Value Measurements Using Significant Unobservable Inputs (Level 3) Equity Options</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_FairValueMeasurementsUsingSignificantUnobservableInputsLevel3EquityOptionsMember' xlink:to='lab_fil_FairValueMeasurementsUsingSignificantUnobservableInputsLevel3EquityOptionsMember'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_NotesReceivable' xlink:label='fil_NotesReceivable'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NotesReceivable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Notes receivable {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NotesReceivable' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Notes receivable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NotesReceivable' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Notes receivable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NotesReceivable' xlink:to='lab_fil_NotesReceivable'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_NoteWouldConvertIntoConversionShares' xlink:label='fil_NoteWouldConvertIntoConversionShares'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NoteWouldConvertIntoConversionShares' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note would convert into Conversion Shares</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NoteWouldConvertIntoConversionShares' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Note would convert into Conversion Shares</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NoteWouldConvertIntoConversionShares' xlink:to='lab_fil_NoteWouldConvertIntoConversionShares'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_NoteBoreInterestPerAnnumIncreasedToAnnualInterest' xlink:label='fil_NoteBoreInterestPerAnnumIncreasedToAnnualInterest'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NoteBoreInterestPerAnnumIncreasedToAnnualInterest' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note bore interest per annum increased to annual interest</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NoteBoreInterestPerAnnumIncreasedToAnnualInterest' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Note bore interest per annum increased to annual interest</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NoteBoreInterestPerAnnumIncreasedToAnnualInterest' xlink:to='lab_fil_NoteBoreInterestPerAnnumIncreasedToAnnualInterest'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_SharesOfMentorStockExerciseOfSeriesDWarrantsPerShare' xlink:label='fil_SharesOfMentorStockExerciseOfSeriesDWarrantsPerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_SharesOfMentorStockExerciseOfSeriesDWarrantsPerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Shares of Mentor stock exercise of series D warrants per share</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_SharesOfMentorStockExerciseOfSeriesDWarrantsPerShare' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Shares of Mentor stock exercise of series D warrants per share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_SharesOfMentorStockExerciseOfSeriesDWarrantsPerShare' xlink:to='lab_fil_SharesOfMentorStockExerciseOfSeriesDWarrantsPerShare'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_BhangOwnersScottVanRixelAndRichardSellersWhoTogetherPurchasedShares' xlink:label='fil_BhangOwnersScottVanRixelAndRichardSellersWhoTogetherPurchasedShares'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BhangOwnersScottVanRixelAndRichardSellersWhoTogetherPurchasedShares' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Bhang owners, Scott Van Rixel and Richard Sellers, who together purchased shares</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_BhangOwnersScottVanRixelAndRichardSellersWhoTogetherPurchasedShares' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Bhang owners, Scott Van Rixel and Richard Sellers, who together purchased shares</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BhangOwnersScottVanRixelAndRichardSellersWhoTogetherPurchasedShares' xlink:to='lab_fil_BhangOwnersScottVanRixelAndRichardSellersWhoTogetherPurchasedShares'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ConvertibleNoteReceivableNarrativeAbstract' xlink:label='fil_ConvertibleNoteReceivableNarrativeAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertibleNoteReceivableNarrativeAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Convertible note receivable (Narrative)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertibleNoteReceivableNarrativeAbstract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company raised from warrant redemption fees</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConvertibleNoteReceivableNarrativeAbstract' xlink:to='lab_fil_ConvertibleNoteReceivableNarrativeAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ScheduleOfOperatingSegmentsAndCorporateUnallocatedOperatingIncomeLossToConsolidatedIncomeBeforeIncomeTaxesTableTextBlock' xlink:label='fil_ScheduleOfOperatingSegmentsAndCorporateUnallocatedOperatingIncomeLossToConsolidatedIncomeBeforeIncomeTaxesTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ScheduleOfOperatingSegmentsAndCorporateUnallocatedOperatingIncomeLossToConsolidatedIncomeBeforeIncomeTaxesTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of operating segments and corporate-unallocated operating income (loss) to consolidated income before income taxes {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ScheduleOfOperatingSegmentsAndCorporateUnallocatedOperatingIncomeLossToConsolidatedIncomeBeforeIncomeTaxesTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Schedule of operating segments and corporate-unallocated operating income (loss) to consolidated income before income taxes</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ScheduleOfOperatingSegmentsAndCorporateUnallocatedOperatingIncomeLossToConsolidatedIncomeBeforeIncomeTaxesTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Tabular disclosure for operating segments and corporate-unallocated operating income (loss) to consolidated income before income taxes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ScheduleOfOperatingSegmentsAndCorporateUnallocatedOperatingIncomeLossToConsolidatedIncomeBeforeIncomeTaxesTableTextBlock' xlink:to='lab_fil_ScheduleOfOperatingSegmentsAndCorporateUnallocatedOperatingIncomeLossToConsolidatedIncomeBeforeIncomeTaxesTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock' xlink:label='us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of summary of common stock warrants (Tables) {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Schedule of summary of common stock warrants (Tables)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock' xlink:to='lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_OtherLiabilitiesAbstract1' xlink:label='fil_OtherLiabilitiesAbstract1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_OtherLiabilitiesAbstract1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of summary of common stock warrants (Tables)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_OtherLiabilitiesAbstract1' xlink:to='lab_fil_OtherLiabilitiesAbstract1'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock' xlink:label='us-gaap_PropertyPlantAndEquipmentPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property, equipment and machinery</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentPolicyTextBlock' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtTextBlock' xlink:label='us-gaap_LongTermDebtTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LongTermDebtTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Long term debt and revolving line of credit</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LongTermDebtTextBlock' xlink:to='lab_us-gaap_LongTermDebtTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_StockholdersEquityAbstract1' xlink:label='fil_StockholdersEquityAbstract1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_StockholdersEquityAbstract1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stockholders&apos; equity:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_StockholdersEquityAbstract1' xlink:to='lab_fil_StockholdersEquityAbstract1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_NotePurchaseAgreementAndConsultingAgreementWithGFarmalabsLimitedAbstract' xlink:label='fil_NotePurchaseAgreementAndConsultingAgreementWithGFarmalabsLimitedAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NotePurchaseAgreementAndConsultingAgreementWithGFarmalabsLimitedAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note purchase agreement and consulting agreement with G FarmaLabs Limited</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NotePurchaseAgreementAndConsultingAgreementWithGFarmalabsLimitedAbstract' xlink:to='lab_fil_NotePurchaseAgreementAndConsultingAgreementWithGFarmalabsLimitedAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_InvestmentInAccountReceivableAbstract' xlink:label='fil_InvestmentInAccountReceivableAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InvestmentInAccountReceivableAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Investment in account receivable:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InvestmentInAccountReceivableAbstract' xlink:to='lab_fil_InvestmentInAccountReceivableAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock' xlink:label='us-gaap_SignificantAccountingPoliciesTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SignificantAccountingPoliciesTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Summary of significant accounting policies {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SignificantAccountingPoliciesTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Summary of significant accounting policies</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SignificantAccountingPoliciesTextBlock' xlink:to='lab_us-gaap_SignificantAccountingPoliciesTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit' xlink:label='us-gaap_IncomeTaxExpenseBenefit'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeTaxExpenseBenefit' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Provision for income taxes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeTaxExpenseBenefit' xlink:to='lab_us-gaap_IncomeTaxExpenseBenefit'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' xlink:label='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Income (loss) before provision for income taxes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' xlink:to='lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues' xlink:label='us-gaap_Revenues'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Revenues' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total revenue</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Revenues' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Total revenue</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Revenues' xlink:to='lab_us-gaap_Revenues'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity' xlink:label='us-gaap_LiabilitiesAndStockholdersEquity'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesAndStockholdersEquity' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total liabilities and shareholders&apos; equity</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesAndStockholdersEquity' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Total liabilities and shareholders&apos; equity</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesAndStockholdersEquity' xlink:to='lab_us-gaap_LiabilitiesAndStockholdersEquity'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity' xlink:label='us-gaap_StockholdersEquity'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquity' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total shareholders&apos; equity</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockholdersEquity' xlink:to='lab_us-gaap_StockholdersEquity'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit' xlink:label='us-gaap_RetainedEarningsAccumulatedDeficit'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RetainedEarningsAccumulatedDeficit' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accumulated deficit</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RetainedEarningsAccumulatedDeficit' xlink:to='lab_us-gaap_RetainedEarningsAccumulatedDeficit'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepositsAssetsNoncurrent' xlink:label='us-gaap_DepositsAssetsNoncurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DepositsAssetsNoncurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Deposits {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DepositsAssetsNoncurrent' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Deposits</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DepositsAssetsNoncurrent' xlink:to='lab_us-gaap_DepositsAssetsNoncurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag' xlink:label='dei_AmendmentFlag'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_AmendmentFlag' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amendment Flag</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_AmendmentFlag' xlink:to='lab_dei_AmendmentFlag'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_CompanyIncreasedTheTotalAmountInvestedInGFarmaFrom500000' xlink:label='fil_CompanyIncreasedTheTotalAmountInvestedInGFarmaFrom500000'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyIncreasedTheTotalAmountInvestedInGFarmaFrom500000' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company increased the total amount invested in G Farma from $500,000</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyIncreasedTheTotalAmountInvestedInGFarmaFrom500000' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company increased the total amount invested in G Farma from $500,000</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanyIncreasedTheTotalAmountInvestedInGFarmaFrom500000' xlink:to='lab_fil_CompanyIncreasedTheTotalAmountInvestedInGFarmaFrom500000'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_MentorEnteredIntoAnAgreementToProvideFundingToOffsetCostsOfTheApplication' xlink:label='fil_MentorEnteredIntoAnAgreementToProvideFundingToOffsetCostsOfTheApplication'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_MentorEnteredIntoAnAgreementToProvideFundingToOffsetCostsOfTheApplication' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Mentor entered into an agreement to provide funding to offset costs of the application</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_MentorEnteredIntoAnAgreementToProvideFundingToOffsetCostsOfTheApplication' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Mentor entered into an agreement to provide funding to offset costs of the application</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_MentorEnteredIntoAnAgreementToProvideFundingToOffsetCostsOfTheApplication' xlink:to='lab_fil_MentorEnteredIntoAnAgreementToProvideFundingToOffsetCostsOfTheApplication'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_BeginningBalance1' xlink:label='fil_BeginningBalance1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BeginningBalance1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Beginning balance</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_BeginningBalance1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Beginning balance</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BeginningBalance1' xlink:to='lab_fil_BeginningBalance1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_NetSales4' xlink:label='fil_NetSales4'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetSales4' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net sales;</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetSales4' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Consolidated - Net sales</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NetSales4' xlink:to='lab_fil_NetSales4'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PropertyAdditions1' xlink:label='fil_PropertyAdditions1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PropertyAdditions1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property additions,</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PropertyAdditions1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Trash Management - Property Additions.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PropertyAdditions1' xlink:to='lab_fil_PropertyAdditions1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PaidForTheInternationalLicensingRights' xlink:label='fil_PaidForTheInternationalLicensingRights'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PaidForTheInternationalLicensingRights' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Paid for the international licensing rights</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PaidForTheInternationalLicensingRights' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Paid for the international licensing rights</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PaidForTheInternationalLicensingRights' xlink:to='lab_fil_PaidForTheInternationalLicensingRights'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_IncentiveFeeIncreaseInMarketCapitalization1' xlink:label='fil_IncentiveFeeIncreaseInMarketCapitalization1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncentiveFeeIncreaseInMarketCapitalization1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Incentive fee increase in market capitalization</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncentiveFeeIncreaseInMarketCapitalization1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Incentive fee increase in market capitalization</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IncentiveFeeIncreaseInMarketCapitalization1' xlink:to='lab_fil_IncentiveFeeIncreaseInMarketCapitalization1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_LessCurrentMaturities' xlink:label='fil_LessCurrentMaturities'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LessCurrentMaturities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Less: Current maturities</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LessCurrentMaturities' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount of long-term debt, after unamortized discount or premium, scheduled to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LessCurrentMaturities' xlink:to='lab_fil_LessCurrentMaturities'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_CommonStockAuthorizedShares' xlink:label='fil_CommonStockAuthorizedShares'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonStockAuthorizedShares' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common stock authorized shares</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonStockAuthorizedShares' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The maximum number of common shares permitted to be issued by an entity&apos;s charter and bylaws.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CommonStockAuthorizedShares' xlink:to='lab_fil_CommonStockAuthorizedShares'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_WarrantsIssued1' xlink:label='fil_WarrantsIssued1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsIssued1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrants Issued {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsIssued1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Warrants Issued</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsIssued1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Warrants Issued</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantsIssued1' xlink:to='lab_fil_WarrantsIssued1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_SummarizesCommonStockWarrantsAbstract' xlink:label='fil_SummarizesCommonStockWarrantsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_SummarizesCommonStockWarrantsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Summarizes Common Stock Warrants</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_SummarizesCommonStockWarrantsAbstract' xlink:to='lab_fil_SummarizesCommonStockWarrantsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_TotalGainsOrLosses1Abstract' xlink:label='fil_TotalGainsOrLosses1Abstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalGainsOrLosses1Abstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total gains or losses {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalGainsOrLosses1Abstract' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Total gains or losses</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalGainsOrLosses1Abstract' xlink:to='lab_fil_TotalGainsOrLosses1Abstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_GFarmaPurchasedRestrictedSharesOfTheCompanySCommonStockAtAPricePerShare' xlink:label='fil_GFarmaPurchasedRestrictedSharesOfTheCompanySCommonStockAtAPricePerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_GFarmaPurchasedRestrictedSharesOfTheCompanySCommonStockAtAPricePerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>G Farma purchased restricted shares of the Company&apos;s Common Stock at a price per share</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_GFarmaPurchasedRestrictedSharesOfTheCompanySCommonStockAtAPricePerShare' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>G Farma purchased restricted shares of the Company&apos;s Common Stock at a price per share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_GFarmaPurchasedRestrictedSharesOfTheCompanySCommonStockAtAPricePerShare' xlink:to='lab_fil_GFarmaPurchasedRestrictedSharesOfTheCompanySCommonStockAtAPricePerShare'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_CompanyWillReceiveAMonthlyConsultingFeePerMonth' xlink:label='fil_CompanyWillReceiveAMonthlyConsultingFeePerMonth'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyWillReceiveAMonthlyConsultingFeePerMonth' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company will receive a monthly consulting fee per month</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyWillReceiveAMonthlyConsultingFeePerMonth' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company will receive a monthly consulting fee per month</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanyWillReceiveAMonthlyConsultingFeePerMonth' xlink:to='lab_fil_CompanyWillReceiveAMonthlyConsultingFeePerMonth'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ConvertibleNotesReceivableNarrativeDetailsAbstract' xlink:label='fil_ConvertibleNotesReceivableNarrativeDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertibleNotesReceivableNarrativeDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Convertible notes receivable Narrative Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConvertibleNotesReceivableNarrativeDetailsAbstract' xlink:to='lab_fil_ConvertibleNotesReceivableNarrativeDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PropertyAndEquipmentDuringThePeriodAbstract' xlink:label='fil_PropertyAndEquipmentDuringThePeriodAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PropertyAndEquipmentDuringThePeriodAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property and equipment During the period</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PropertyAndEquipmentDuringThePeriodAbstract' xlink:to='lab_fil_PropertyAndEquipmentDuringThePeriodAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_AmortizationDetailsAbstract' xlink:label='fil_AmortizationDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AmortizationDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amortization details</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AmortizationDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Discount amortization is included in interest income</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AmortizationDetailsAbstract' xlink:to='lab_fil_AmortizationDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ReceivableFromBhangChocolateCompany' xlink:label='fil_ReceivableFromBhangChocolateCompany'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ReceivableFromBhangChocolateCompany' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Receivable from Bhang Chocolate Company</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ReceivableFromBhangChocolateCompany' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Receivable from Bhang Chocolate Company</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ReceivableFromBhangChocolateCompany' xlink:to='lab_fil_ReceivableFromBhangChocolateCompany'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PrepaidLegalExpense' xlink:label='fil_PrepaidLegalExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PrepaidLegalExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Prepaid legal expense</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PrepaidLegalExpense' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Prepaid legal expense</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PrepaidLegalExpense' xlink:to='lab_fil_PrepaidLegalExpense'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_GoodwillDetailsAbstract' xlink:label='fil_GoodwillDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_GoodwillDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Goodwill Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_GoodwillDetailsAbstract' xlink:to='lab_fil_GoodwillDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_JudgmentAlsoAccruesPostJudgmentInterestsAtTheRateOf' xlink:label='fil_JudgmentAlsoAccruesPostJudgmentInterestsAtTheRateOf'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_JudgmentAlsoAccruesPostJudgmentInterestsAtTheRateOf' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Judgment also accrues post-judgment interests at the rate of</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_JudgmentAlsoAccruesPostJudgmentInterestsAtTheRateOf' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Judgment also accrues post-judgment interests at the rate of</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_JudgmentAlsoAccruesPostJudgmentInterestsAtTheRateOf' xlink:to='lab_fil_JudgmentAlsoAccruesPostJudgmentInterestsAtTheRateOf'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ScheduleOfInvestmentInAccountReceivableSupportedByAnExchangeAgreementTableTextBlock' xlink:label='fil_ScheduleOfInvestmentInAccountReceivableSupportedByAnExchangeAgreementTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ScheduleOfInvestmentInAccountReceivableSupportedByAnExchangeAgreementTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Investment in account receivable supported by an exchange agreement (Tables)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ScheduleOfInvestmentInAccountReceivableSupportedByAnExchangeAgreementTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Tabular disclosure of receivables or notes with discounts or premiums resulting from the determination of present value in cash or noncash transactions, including description of the receivable, the effective interest rate, the face amount, amortization period and method.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ScheduleOfInvestmentInAccountReceivableSupportedByAnExchangeAgreementTableTextBlock' xlink:to='lab_fil_ScheduleOfInvestmentInAccountReceivableSupportedByAnExchangeAgreementTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock' xlink:label='us-gaap_IncomeTaxPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeTaxPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Income taxes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeTaxPolicyTextBlock' xlink:to='lab_us-gaap_IncomeTaxPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock' xlink:label='us-gaap_RevenueRecognitionPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RevenueRecognitionPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Revenue recognition</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RevenueRecognitionPolicyTextBlock' xlink:to='lab_us-gaap_RevenueRecognitionPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_LeaseCommitmentsAbstract' xlink:label='fil_LeaseCommitmentsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LeaseCommitmentsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Lease commitments:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LeaseCommitmentsAbstract' xlink:to='lab_fil_LeaseCommitmentsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt' xlink:label='us-gaap_RepaymentsOfLongTermDebt'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RepaymentsOfLongTermDebt' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Payments on long-term debt</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RepaymentsOfLongTermDebt' xlink:to='lab_us-gaap_RepaymentsOfLongTermDebt'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:label='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Adjustments to reconcile net income (loss) to net cash provided by (used by) operating activities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity' xlink:label='us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Gain (loss) attributable to non-controlling interest</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity' xlink:to='lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss' xlink:label='us-gaap_NetIncomeLoss'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetIncomeLoss' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net income (loss)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetIncomeLoss' xlink:to='lab_us-gaap_NetIncomeLoss'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized' xlink:label='us-gaap_CommonStockSharesAuthorized'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockSharesAuthorized' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common Stock, Shares Authorized</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockSharesAuthorized' xlink:to='lab_us-gaap_CommonStockSharesAuthorized'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital' xlink:label='us-gaap_AdditionalPaidInCapital'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AdditionalPaidInCapital' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Additional paid in capital</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AdditionalPaidInCapital' xlink:to='lab_us-gaap_AdditionalPaidInCapital'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent' xlink:label='us-gaap_LongTermDebtNoncurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LongTermDebtNoncurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Long term debt, net of current portion</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LongTermDebtNoncurrent' xlink:to='lab_us-gaap_LongTermDebtNoncurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent' xlink:label='us-gaap_AccruedLiabilitiesCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccruedLiabilitiesCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrued expenses</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccruedLiabilitiesCurrent' xlink:to='lab_us-gaap_AccruedLiabilitiesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets' xlink:label='us-gaap_Assets'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Assets' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Assets' xlink:to='lab_us-gaap_Assets'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill' xlink:label='us-gaap_Goodwill'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Goodwill' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Goodwill</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Goodwill' xlink:to='lab_us-gaap_Goodwill'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNet' xlink:label='us-gaap_AccountsReceivableNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccountsReceivableNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounts receivable, net</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccountsReceivableNet' xlink:to='lab_us-gaap_AccountsReceivableNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory' xlink:label='dei_EntityFilerCategory'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityFilerCategory' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Filer Category</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityFilerCategory' xlink:to='lab_dei_EntityFilerCategory'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_CompanyReceivedFromWarrantRedemptions' xlink:label='fil_CompanyReceivedFromWarrantRedemptions'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyReceivedFromWarrantRedemptions' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company received from warrant redemptions</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyReceivedFromWarrantRedemptions' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company received from warrant redemptions</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanyReceivedFromWarrantRedemptions' xlink:to='lab_fil_CompanyReceivedFromWarrantRedemptions'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_InterestIncome' xlink:label='fil_InterestIncome'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestIncome' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest income {2}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestIncome' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Interest income</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestIncome' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Interest income</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InterestIncome' xlink:to='lab_fil_InterestIncome'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_NetSales3' xlink:label='fil_NetSales3'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetSales3' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net sales.</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetSales3' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Corporate unallocated and Eliminations - Net sales</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NetSales3' xlink:to='lab_fil_NetSales3'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_InterestIncome1' xlink:label='fil_InterestIncome1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestIncome1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest income {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestIncome1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Interest income</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestIncome1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The aggregate interest and fee income generated by: (1) loans the Entity has positive intent and ability to hold for the foreseeable future, or until maturity or payoff, including commercial and consumer loans, whether domestic or foreign, which may consist of: (a) industrial and agricultural; (b) real estate; and (c) real estate construction loans; (d) trade financing; (e) lease financing; (f) home equity lines-of-credit; (g) automobile and other vehicle loans; and (h) credit card and other revolving-type loans and (2) loans and leases held-for-sale which may include mortgage loans, direct financing, and sales-type leases.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InterestIncome1' xlink:to='lab_fil_InterestIncome1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_BondStreetServicingLlcAtInterestPerAnnum' xlink:label='fil_BondStreetServicingLlcAtInterestPerAnnum'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BondStreetServicingLlcAtInterestPerAnnum' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Bond Street Servicing, LLC interest per annum</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_BondStreetServicingLlcAtInterestPerAnnum' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>.Bond Street Servicing, LLC at interest per annum</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BondStreetServicingLlcAtInterestPerAnnum' xlink:to='lab_fil_BondStreetServicingLlcAtInterestPerAnnum'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_CommercialCreditAgreementWithBondStreetServicingLlcAt116InterestPerAnnumSemiMonthlyPaymentsOf1648MaturingOctober162019NetOf3390And3723UnamortizedLoanServiceFeeRespectively' xlink:label='fil_CommercialCreditAgreementWithBondStreetServicingLlcAt116InterestPerAnnumSemiMonthlyPaymentsOf1648MaturingOctober162019NetOf3390And3723UnamortizedLoanServiceFeeRespectively'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommercialCreditAgreementWithBondStreetServicingLlcAt116InterestPerAnnumSemiMonthlyPaymentsOf1648MaturingOctober162019NetOf3390And3723UnamortizedLoanServiceFeeRespectively' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Commercial credit agreement with Bond Street Servicing, LLC at 11.6% interest per annum, semi-monthly payments of $1,648, maturing October 16, 2019. Net of $3,390 and $3,723 unamortized loan service fee, respectively.</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommercialCreditAgreementWithBondStreetServicingLlcAt116InterestPerAnnumSemiMonthlyPaymentsOf1648MaturingOctober162019NetOf3390And3723UnamortizedLoanServiceFeeRespectively' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Commercial credit agreement with Bond Street Servicing, LLC at 11.6% interest per annum, semi-monthly payments of $1,648, maturing October 16, 2019. Net of $3,390 and $3,723 unamortized loan service fee, respectively.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CommercialCreditAgreementWithBondStreetServicingLlcAt116InterestPerAnnumSemiMonthlyPaymentsOf1648MaturingOctober162019NetOf3390And3723UnamortizedLoanServiceFeeRespectively' xlink:to='lab_fil_CommercialCreditAgreementWithBondStreetServicingLlcAt116InterestPerAnnumSemiMonthlyPaymentsOf1648MaturingOctober162019NetOf3390And3723UnamortizedLoanServiceFeeRespectively'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_AnnualMinimumLeasePaymentsDetailsAbstract' xlink:label='fil_AnnualMinimumLeasePaymentsDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AnnualMinimumLeasePaymentsDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Annual minimum lease payments Details:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AnnualMinimumLeasePaymentsDetailsAbstract' xlink:to='lab_fil_AnnualMinimumLeasePaymentsDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_Issued' xlink:label='fil_Issued'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Issued' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issued</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Issued' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Issued' xlink:to='lab_fil_Issued'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_SeriesB' xlink:label='fil_SeriesB'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_SeriesB' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Series B</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_SeriesB' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Series B Common Stock Warrant Exercise Price</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_SeriesB' xlink:to='lab_fil_SeriesB'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_IncludedInEarningsOrChangesInNetAssets' xlink:label='fil_IncludedInEarningsOrChangesInNetAssets'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncludedInEarningsOrChangesInNetAssets' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Included in earnings (or changes in net assets)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncludedInEarningsOrChangesInNetAssets' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Included in earnings (or changes in net assets)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IncludedInEarningsOrChangesInNetAssets' xlink:to='lab_fil_IncludedInEarningsOrChangesInNetAssets'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_NotePurchaseAgreementAndConsultingAgreementWithGFarmalabsLimitedDetailsAbstract' xlink:label='fil_NotePurchaseAgreementAndConsultingAgreementWithGFarmalabsLimitedDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NotePurchaseAgreementAndConsultingAgreementWithGFarmalabsLimitedDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note purchase agreement and consulting agreement with G FarmaLabs Limited Details</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NotePurchaseAgreementAndConsultingAgreementWithGFarmalabsLimitedDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>NeuCourt, Inc. convertible note receivable including accrued interest of $489 and $181 at March 31, 2017</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NotePurchaseAgreementAndConsultingAgreementWithGFarmalabsLimitedDetailsAbstract' xlink:to='lab_fil_NotePurchaseAgreementAndConsultingAgreementWithGFarmalabsLimitedDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_Computers' xlink:label='fil_Computers'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Computers' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Computers</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Computers' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Computers' xlink:to='lab_fil_Computers'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_SharesOfMentorStockExerciseOfSeriesDWarrants' xlink:label='fil_SharesOfMentorStockExerciseOfSeriesDWarrants'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_SharesOfMentorStockExerciseOfSeriesDWarrants' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Shares of Mentor stock exercise of series D warrants</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_SharesOfMentorStockExerciseOfSeriesDWarrants' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Shares of Mentor stock exercise of series D warrants</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_SharesOfMentorStockExerciseOfSeriesDWarrants' xlink:to='lab_fil_SharesOfMentorStockExerciseOfSeriesDWarrants'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_MentorObtainedAJudgmentInTheAmountAgainstBhangCorporation' xlink:label='fil_MentorObtainedAJudgmentInTheAmountAgainstBhangCorporation'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_MentorObtainedAJudgmentInTheAmountAgainstBhangCorporation' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Mentor obtained a judgment in the amount against Bhang Corporation</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_MentorObtainedAJudgmentInTheAmountAgainstBhangCorporation' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Mentor obtained a judgment in the amount against Bhang Corporation</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_MentorObtainedAJudgmentInTheAmountAgainstBhangCorporation' xlink:to='lab_fil_MentorObtainedAJudgmentInTheAmountAgainstBhangCorporation'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_GoodwillWasDerivedFromConsolidatingWciEffectiveJanuary120141OfAcquisition' xlink:label='fil_GoodwillWasDerivedFromConsolidatingWciEffectiveJanuary120141OfAcquisition'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_GoodwillWasDerivedFromConsolidatingWciEffectiveJanuary120141OfAcquisition' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Goodwill was derived from consolidating WCI effective January 1, 2014</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_GoodwillWasDerivedFromConsolidatingWciEffectiveJanuary120141OfAcquisition' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Goodwill was derived from consolidating WCI effective January 1, 2014 - 1% of acquisition</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_GoodwillWasDerivedFromConsolidatingWciEffectiveJanuary120141OfAcquisition' xlink:to='lab_fil_GoodwillWasDerivedFromConsolidatingWciEffectiveJanuary120141OfAcquisition'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_AcquiredOwnershipInBhangChocolateCompanyInc' xlink:label='fil_AcquiredOwnershipInBhangChocolateCompanyInc'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AcquiredOwnershipInBhangChocolateCompanyInc' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Acquired ownership in Bhang Chocolate Company, Inc.</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AcquiredOwnershipInBhangChocolateCompanyInc' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Acquired ownership in Bhang Chocolate Company, Inc.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AcquiredOwnershipInBhangChocolateCompanyInc' xlink:to='lab_fil_AcquiredOwnershipInBhangChocolateCompanyInc'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock' xlink:label='us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accumulated other comprehensive income (loss) {3}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Accumulated other comprehensive income (loss)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ScheduleOfConvertibleNoteReceivableTablesAbstract' xlink:label='fil_ScheduleOfConvertibleNoteReceivableTablesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ScheduleOfConvertibleNoteReceivableTablesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Convertible note receivable (Tables):</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ScheduleOfConvertibleNoteReceivableTablesAbstract' xlink:to='lab_fil_ScheduleOfConvertibleNoteReceivableTablesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentPolicyTextBlock' xlink:label='us-gaap_InvestmentPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InvestmentPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Long term investments {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InvestmentPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Long term investments</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InvestmentPolicyTextBlock' xlink:to='lab_us-gaap_InvestmentPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsTextBlock' xlink:label='us-gaap_SubsequentEventsTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SubsequentEventsTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Subsequent events</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SubsequentEventsTextBlock' xlink:to='lab_us-gaap_SubsequentEventsTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_CommitmentAndContingenciesAbstract' xlink:label='fil_CommitmentAndContingenciesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommitmentAndContingenciesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Commitment and Contingencies:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CommitmentAndContingenciesAbstract' xlink:to='lab_fil_CommitmentAndContingenciesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_LongTermDebtAndRevolvingLineOfCreditAbstract' xlink:label='fil_LongTermDebtAndRevolvingLineOfCreditAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LongTermDebtAndRevolvingLineOfCreditAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Long term debt and revolving line of credit:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LongTermDebtAndRevolvingLineOfCreditAbstract' xlink:to='lab_fil_LongTermDebtAndRevolvingLineOfCreditAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaid' xlink:label='us-gaap_InterestPaid'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InterestPaid' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash paid for interest</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InterestPaid' xlink:to='lab_us-gaap_InterestPaid'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net cash provided by (used by) financing activities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:to='lab_us-gaap_NetCashProvidedByUsedInFinancingActivities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:to='lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net cash provided by (used by) operating activities</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Net cash provided by (used by) operating activities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='lab_us-gaap_NetCashProvidedByUsedInOperatingActivities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:label='us-gaap_IncreaseDecreaseInAccruedLiabilities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrued expenses {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Accrued expenses</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:to='lab_us-gaap_IncreaseDecreaseInAccruedLiabilities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract' xlink:label='us-gaap_IncreaseDecreaseInOperatingAssetsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Decrease (increase) in operating assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInOperatingAssetsAbstract' xlink:to='lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestIncomeOperating' xlink:label='us-gaap_InterestIncomeOperating'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InterestIncomeOperating' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrued investment interest income</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InterestIncomeOperating' xlink:to='lab_us-gaap_InterestIncomeOperating'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract' xlink:label='us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted average number of shares of Mentor common stock outstanding:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract' xlink:to='lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnInvestments' xlink:label='us-gaap_GainLossOnInvestments'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_GainLossOnInvestments' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Gain (loss) on investments</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_GainLossOnInvestments' xlink:to='lab_us-gaap_GainLossOnInvestments'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense' xlink:label='us-gaap_SellingGeneralAndAdministrativeExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SellingGeneralAndAdministrativeExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Selling, general and administrative expenses</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SellingGeneralAndAdministrativeExpense' xlink:to='lab_us-gaap_SellingGeneralAndAdministrativeExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfServices' xlink:label='us-gaap_CostOfServices'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CostOfServices' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Service fees</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CostOfServices' xlink:to='lab_us-gaap_CostOfServices'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare' xlink:label='us-gaap_CommonStockParOrStatedValuePerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockParOrStatedValuePerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common Stock, Par Value</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockParOrStatedValuePerShare' xlink:to='lab_us-gaap_CommonStockParOrStatedValuePerShare'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue' xlink:label='us-gaap_PreferredStockValue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PreferredStockValue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred stock, $0.0001 par value, 5,000,000 shares authorized; no shares issued and outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PreferredStockValue' xlink:to='lab_us-gaap_PreferredStockValue'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrent' xlink:label='us-gaap_LiabilitiesNoncurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesNoncurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total long-term liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesNoncurrent' xlink:to='lab_us-gaap_LiabilitiesNoncurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedSalariesCurrentAndNoncurrent' xlink:label='us-gaap_AccruedSalariesCurrentAndNoncurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccruedSalariesCurrentAndNoncurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrued salary, retirement and incentive fee - related party</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccruedSalariesCurrentAndNoncurrent' xlink:to='lab_us-gaap_AccruedSalariesCurrentAndNoncurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtCurrent' xlink:label='us-gaap_LongTermDebtCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LongTermDebtCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current portion of long term debt</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LongTermDebtCurrent' xlink:to='lab_us-gaap_LongTermDebtCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus' xlink:label='dei_DocumentFiscalYearFocus'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentFiscalYearFocus' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document Fiscal Year Focus</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentFiscalYearFocus' xlink:to='lab_dei_DocumentFiscalYearFocus'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding' xlink:label='dei_EntityCommonStockSharesOutstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCommonStockSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Common Stock, Shares Outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCommonStockSharesOutstanding' xlink:to='lab_dei_EntityCommonStockSharesOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_MonthlyPaymentsOfPrincipalAndInterestPerMonth' xlink:label='fil_MonthlyPaymentsOfPrincipalAndInterestPerMonth'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_MonthlyPaymentsOfPrincipalAndInterestPerMonth' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Monthly payments of principal and interest per month</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_MonthlyPaymentsOfPrincipalAndInterestPerMonth' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Monthly payments of principal and interest per month</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_MonthlyPaymentsOfPrincipalAndInterestPerMonth' xlink:to='lab_fil_MonthlyPaymentsOfPrincipalAndInterestPerMonth'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_GainsLossesOnAvailableForSaleSecurities' xlink:label='fil_GainsLossesOnAvailableForSaleSecurities'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_GainsLossesOnAvailableForSaleSecurities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Gains (losses) on available for sale securities</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_GainsLossesOnAvailableForSaleSecurities' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Gains (losses) on available for sale securities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_GainsLossesOnAvailableForSaleSecurities' xlink:to='lab_fil_GainsLossesOnAvailableForSaleSecurities'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_TotalAssets1' xlink:label='fil_TotalAssets1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalAssets1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total assets.</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalAssets1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalAssets1' xlink:to='lab_fil_TotalAssets1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_AsPartOfTheJudgmentBhangOwnersScottVanRixelAndRichardSellersWhoTogetherPurchasedShares1' xlink:label='fil_AsPartOfTheJudgmentBhangOwnersScottVanRixelAndRichardSellersWhoTogetherPurchasedShares1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AsPartOfTheJudgmentBhangOwnersScottVanRixelAndRichardSellersWhoTogetherPurchasedShares1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>As part of the judgment Bhang owners, Scott Van Rixel and Richard Sellers, who together purchased shares</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AsPartOfTheJudgmentBhangOwnersScottVanRixelAndRichardSellersWhoTogetherPurchasedShares1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>As part of the judgment Bhang owners, Scott Van Rixel and Richard Sellers, who together purchased shares</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AsPartOfTheJudgmentBhangOwnersScottVanRixelAndRichardSellersWhoTogetherPurchasedShares1' xlink:to='lab_fil_AsPartOfTheJudgmentBhangOwnersScottVanRixelAndRichardSellersWhoTogetherPurchasedShares1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_AccruedIncentiveFeeAndBonusExpense' xlink:label='fil_AccruedIncentiveFeeAndBonusExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccruedIncentiveFeeAndBonusExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrued incentive fee and bonus expense</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccruedIncentiveFeeAndBonusExpense' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Accrued incentive fee and bonus expense</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AccruedIncentiveFeeAndBonusExpense' xlink:to='lab_fil_AccruedIncentiveFeeAndBonusExpense'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_CompanyAgreedToAdvanceTheCeoAgainstTheAccruedLiabilities' xlink:label='fil_CompanyAgreedToAdvanceTheCeoAgainstTheAccruedLiabilities'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyAgreedToAdvanceTheCeoAgainstTheAccruedLiabilities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company agreed to advance the CEO against the accrued liabilities</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyAgreedToAdvanceTheCeoAgainstTheAccruedLiabilities' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company agreed to advance the CEO against the accrued liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanyAgreedToAdvanceTheCeoAgainstTheAccruedLiabilities' xlink:to='lab_fil_CompanyAgreedToAdvanceTheCeoAgainstTheAccruedLiabilities'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_LongTermDebtDetailsAbstract' xlink:label='fil_LongTermDebtDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LongTermDebtDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Long term debt Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LongTermDebtDetailsAbstract' xlink:to='lab_fil_LongTermDebtDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_OutstandingEFGAndHWarrants1' xlink:label='fil_OutstandingEFGAndHWarrants1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_OutstandingEFGAndHWarrants1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Outstanding E, F, G and H Warrants {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_OutstandingEFGAndHWarrants1' xlink:role='http://www.xbrl.org/2003/role/periodStartLabel' xml:lang='en-US'>Outstanding E, F, G and H Warrants</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_OutstandingEFGAndHWarrants1' xlink:role='http://www.xbrl.org/2003/role/periodEndLabel' xml:lang='en-US'>Outstanding E, F, G and H Warrants</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_OutstandingEFGAndHWarrants1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of warrants or rights outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_OutstandingEFGAndHWarrants1' xlink:to='lab_fil_OutstandingEFGAndHWarrants1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_IntrinsicValueOfOutstandingWarrants' xlink:label='fil_IntrinsicValueOfOutstandingWarrants'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IntrinsicValueOfOutstandingWarrants' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Intrinsic value of outstanding warrants</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IntrinsicValueOfOutstandingWarrants' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Intrinsic value of outstanding warrants</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IntrinsicValueOfOutstandingWarrants' xlink:to='lab_fil_IntrinsicValueOfOutstandingWarrants'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_Settlements' xlink:label='fil_Settlements'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Settlements' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Settlements</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Settlements' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Cash received or short term receivables for unsettled money transfers, money orders, consumer payments, or business to business payments. Settlement assets include clearing and settling customers payments due to and from financial institutions and may include cash and cash equivalents.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Settlements' xlink:to='lab_fil_Settlements'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_Balance1' xlink:label='fil_Balance1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Balance1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Balance {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Balance1' xlink:role='http://www.xbrl.org/2003/role/periodStartLabel' xml:lang='en-US'>Balance</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Balance1' xlink:role='http://www.xbrl.org/2003/role/periodEndLabel' xml:lang='en-US'>Balance</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Balance1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Balance</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Balance1' xlink:to='lab_fil_Balance1'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StatementLineItems' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Statement [Line Items]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StatementLineItems' xlink:to='lab_us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_RequiresMonthlyPaymentsOf1107WithABalloonPaymentAtMaturity' xlink:label='fil_RequiresMonthlyPaymentsOf1107WithABalloonPaymentAtMaturity'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RequiresMonthlyPaymentsOf1107WithABalloonPaymentAtMaturity' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Requires monthly payments of $1,107 with a balloon payment at maturity</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_RequiresMonthlyPaymentsOf1107WithABalloonPaymentAtMaturity' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Requires monthly payments of $1,107 with a balloon payment at maturity</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RequiresMonthlyPaymentsOf1107WithABalloonPaymentAtMaturity' xlink:to='lab_fil_RequiresMonthlyPaymentsOf1107WithABalloonPaymentAtMaturity'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PaymentsOfPrincipalAndInterestInTheAmount' xlink:label='fil_PaymentsOfPrincipalAndInterestInTheAmount'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PaymentsOfPrincipalAndInterestInTheAmount' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Payments of principal and interest in the amount</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PaymentsOfPrincipalAndInterestInTheAmount' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Payments of principal and interest in the amount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PaymentsOfPrincipalAndInterestInTheAmount' xlink:to='lab_fil_PaymentsOfPrincipalAndInterestInTheAmount'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_InvestmentConsistedOfTheFollowingAbstract' xlink:label='fil_InvestmentConsistedOfTheFollowingAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InvestmentConsistedOfTheFollowingAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Investment Consisted Of The Following</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InvestmentConsistedOfTheFollowingAbstract' xlink:to='lab_fil_InvestmentConsistedOfTheFollowingAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_InvestmentInAccountReceivableNarrativeDetailsAbstract' xlink:label='fil_InvestmentInAccountReceivableNarrativeDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InvestmentInAccountReceivableNarrativeDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Investment in account receivable narrative details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InvestmentInAccountReceivableNarrativeDetailsAbstract' xlink:to='lab_fil_InvestmentInAccountReceivableNarrativeDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_AccruedInterest1' xlink:label='fil_AccruedInterest1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccruedInterest1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrued interest</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccruedInterest1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Accrued interest</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AccruedInterest1' xlink:to='lab_fil_AccruedInterest1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ScheduleOfLongTermDebtTablesAbstract' xlink:label='fil_ScheduleOfLongTermDebtTablesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ScheduleOfLongTermDebtTablesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Long Term Debt (Tables)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ScheduleOfLongTermDebtTablesAbstract' xlink:to='lab_fil_ScheduleOfLongTermDebtTablesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock' xlink:label='us-gaap_FairValueMeasurementPolicyPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair value measurements</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueMeasurementPolicyPolicyTextBlock' xlink:to='lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_WarrantsRedemptionLiabilityAbstract' xlink:label='fil_WarrantsRedemptionLiabilityAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsRedemptionLiabilityAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrants redemption liability:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantsRedemptionLiabilityAbstract' xlink:to='lab_fil_WarrantsRedemptionLiabilityAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueOptionTextBlock' xlink:label='us-gaap_FairValueOptionTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueOptionTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Investments and fair value {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueOptionTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Investments and fair value</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueOptionTextBlock' xlink:to='lab_us-gaap_FairValueOptionTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock' xlink:label='us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Bhang Corporation (formerly known as Bhang Chocolate Company, Inc.) and Judgment {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Bhang Corporation (formerly known as Bhang Chocolate Company, Inc.) and Judgment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock' xlink:to='lab_us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable' xlink:label='us-gaap_IncreaseDecreaseInAccountsPayable'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInAccountsPayable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounts payable {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInAccountsPayable' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Accounts payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInAccountsPayable' xlink:to='lab_us-gaap_IncreaseDecreaseInAccountsPayable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable' xlink:label='us-gaap_IncreaseDecreaseInAccountsReceivable'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInAccountsReceivable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounts receivable - trade</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInAccountsReceivable' xlink:to='lab_us-gaap_IncreaseDecreaseInAccountsReceivable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet' xlink:label='us-gaap_OtherOperatingIncomeExpenseNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherOperatingIncomeExpenseNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total other income and (expense)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherOperatingIncomeExpenseNet' xlink:to='lab_us-gaap_OtherOperatingIncomeExpenseNet'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PreferredStockSharesAuthorized1' xlink:label='fil_PreferredStockSharesAuthorized1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PreferredStockSharesAuthorized1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred stock, Shares Authorized</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PreferredStockSharesAuthorized1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Preferred Stock, shares authorized (number of shares), as of the indicated date.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PreferredStockSharesAuthorized1' xlink:to='lab_fil_PreferredStockSharesAuthorized1'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssets' xlink:label='us-gaap_OtherAssets'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherAssets' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total other assets</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherAssets' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Total other assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherAssets' xlink:to='lab_us-gaap_OtherAssets'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ContractualInterestInLegalRecovery' xlink:label='fil_ContractualInterestInLegalRecovery'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ContractualInterestInLegalRecovery' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Contractual interest in legal recovery</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ContractualInterestInLegalRecovery' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Contractual interest in legal recovery</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ContractualInterestInLegalRecovery' xlink:to='lab_fil_ContractualInterestInLegalRecovery'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivablesHeldForSaleAmount' xlink:label='us-gaap_ReceivablesHeldForSaleAmount'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ReceivablesHeldForSaleAmount' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Receivable - Bhang Corporation</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ReceivablesHeldForSaleAmount' xlink:to='lab_us-gaap_ReceivablesHeldForSaleAmount'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentsAndCash' xlink:label='us-gaap_InvestmentsAndCash'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InvestmentsAndCash' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Investments in securities, at fair value</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InvestmentsAndCash' xlink:to='lab_us-gaap_InvestmentsAndCash'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer' xlink:label='dei_EntityWellKnownSeasonedIssuer'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityWellKnownSeasonedIssuer' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Well-known Seasoned Issuer</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityWellKnownSeasonedIssuer' xlink:to='lab_dei_EntityWellKnownSeasonedIssuer'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_FarmaAlsoPurchasedAnAdditionalSharesOfCompanyCommonStock' xlink:label='fil_FarmaAlsoPurchasedAnAdditionalSharesOfCompanyCommonStock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_FarmaAlsoPurchasedAnAdditionalSharesOfCompanyCommonStock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Farma also purchased an additional shares of Company Common Stock</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_FarmaAlsoPurchasedAnAdditionalSharesOfCompanyCommonStock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Farma also purchased an additional shares of Company Common Stock</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_FarmaAlsoPurchasedAnAdditionalSharesOfCompanyCommonStock' xlink:to='lab_fil_FarmaAlsoPurchasedAnAdditionalSharesOfCompanyCommonStock'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PurchaseOfASecondPromissoryNoteInPrincipalFaceAmount' xlink:label='fil_PurchaseOfASecondPromissoryNoteInPrincipalFaceAmount'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PurchaseOfASecondPromissoryNoteInPrincipalFaceAmount' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Purchase of a second promissory note in principal face amount</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PurchaseOfASecondPromissoryNoteInPrincipalFaceAmount' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Purchase of a second promissory note in principal face amount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PurchaseOfASecondPromissoryNoteInPrincipalFaceAmount' xlink:to='lab_fil_PurchaseOfASecondPromissoryNoteInPrincipalFaceAmount'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_NetGainsLossesOnAvailableForSaleSecurities' xlink:label='fil_NetGainsLossesOnAvailableForSaleSecurities'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetGainsLossesOnAvailableForSaleSecurities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net gains (losses) on available for sale securities</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetGainsLossesOnAvailableForSaleSecurities' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Net gains (losses) on available for sale securities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NetGainsLossesOnAvailableForSaleSecurities' xlink:to='lab_fil_NetGainsLossesOnAvailableForSaleSecurities'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_IncomeBeforeTaxes2' xlink:label='fil_IncomeBeforeTaxes2'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncomeBeforeTaxes2' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Income before taxes {2}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncomeBeforeTaxes2' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Income before taxes</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncomeBeforeTaxes2' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Income before taxes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IncomeBeforeTaxes2' xlink:to='lab_fil_IncomeBeforeTaxes2'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_CannabisAndMedicalMarijuanaSegmentAbstract' xlink:label='fil_CannabisAndMedicalMarijuanaSegmentAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CannabisAndMedicalMarijuanaSegmentAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cannabis and Medical Marijuana Segment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CannabisAndMedicalMarijuanaSegmentAbstract' xlink:to='lab_fil_CannabisAndMedicalMarijuanaSegmentAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_OutstandingLiabilityToChiefExecutiveOfficerAbstract' xlink:label='fil_OutstandingLiabilityToChiefExecutiveOfficerAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_OutstandingLiabilityToChiefExecutiveOfficerAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Outstanding liability to Chief Executive Officer</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_OutstandingLiabilityToChiefExecutiveOfficerAbstract' xlink:to='lab_fil_OutstandingLiabilityToChiefExecutiveOfficerAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_FutureMinimumLeasePayments2019' xlink:label='fil_FutureMinimumLeasePayments2019'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_FutureMinimumLeasePayments2019' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Future minimum lease payments 2019</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_FutureMinimumLeasePayments2019' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Future minimum lease payments 2019</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_FutureMinimumLeasePayments2019' xlink:to='lab_fil_FutureMinimumLeasePayments2019'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_Outstanding' xlink:label='fil_Outstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Outstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Outstanding</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Outstanding' xlink:role='http://www.xbrl.org/2003/role/periodStartLabel' xml:lang='en-US'>Outstanding</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Outstanding' xlink:role='http://www.xbrl.org/2003/role/periodEndLabel' xml:lang='en-US'>Outstanding</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Outstanding' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of shares issued which are neither cancelled nor held in the treasury.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Outstanding' xlink:to='lab_fil_Outstanding'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PurchasesIssuancesSalesAndSettlements1Abstract' xlink:label='fil_PurchasesIssuancesSalesAndSettlements1Abstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PurchasesIssuancesSalesAndSettlements1Abstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Purchases, issuances, sales, and settlements {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PurchasesIssuancesSalesAndSettlements1Abstract' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Purchases, issuances, sales, and settlements</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PurchasesIssuancesSalesAndSettlements1Abstract' xlink:to='lab_fil_PurchasesIssuancesSalesAndSettlements1Abstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StatementTable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Statement [Table]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StatementTable' xlink:to='lab_us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_GFarmaPurchasedAnAdditionalSharesOfTheCompanySCommonStockForAnAdditionalPurchasePrice' xlink:label='fil_GFarmaPurchasedAnAdditionalSharesOfTheCompanySCommonStockForAnAdditionalPurchasePrice'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_GFarmaPurchasedAnAdditionalSharesOfTheCompanySCommonStockForAnAdditionalPurchasePrice' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>G Farma purchased an additional shares of the Company&apos;s Common Stock for an additional purchase price</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_GFarmaPurchasedAnAdditionalSharesOfTheCompanySCommonStockForAnAdditionalPurchasePrice' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>G Farma purchased an additional shares of the Company&apos;s Common Stock for an additional purchase price</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_GFarmaPurchasedAnAdditionalSharesOfTheCompanySCommonStockForAnAdditionalPurchasePrice' xlink:to='lab_fil_GFarmaPurchasedAnAdditionalSharesOfTheCompanySCommonStockForAnAdditionalPurchasePrice'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_LessCurrentPortion1' xlink:label='fil_LessCurrentPortion1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LessCurrentPortion1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Less current portion {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LessCurrentPortion1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Less current portion</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LessCurrentPortion1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Less current portion</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LessCurrentPortion1' xlink:to='lab_fil_LessCurrentPortion1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ConversionPriceIsTheElectrumPartnersLlcNoteBalance' xlink:label='fil_ConversionPriceIsTheElectrumPartnersLlcNoteBalance'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConversionPriceIsTheElectrumPartnersLlcNoteBalance' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Conversion price is the Electrum Partners, LLC note balance</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConversionPriceIsTheElectrumPartnersLlcNoteBalance' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Conversion price is the Electrum Partners, LLC note balance</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConversionPriceIsTheElectrumPartnersLlcNoteBalance' xlink:to='lab_fil_ConversionPriceIsTheElectrumPartnersLlcNoteBalance'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_LessCurrentPortion' xlink:label='fil_LessCurrentPortion'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LessCurrentPortion' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Less current portion</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LessCurrentPortion' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Less current portion.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LessCurrentPortion' xlink:to='lab_fil_LessCurrentPortion'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_DepreciationAndAmortization5' xlink:label='fil_DepreciationAndAmortization5'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DepreciationAndAmortization5' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Depreciation and amortization {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_DepreciationAndAmortization5' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Depreciation and amortization</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_DepreciationAndAmortization5' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Depreciation and amortization</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DepreciationAndAmortization5' xlink:to='lab_fil_DepreciationAndAmortization5'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_PropertyAndEquipmentGross' xlink:label='fil_PropertyAndEquipmentGross'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PropertyAndEquipmentGross' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property and equipment gross</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PropertyAndEquipmentGross' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PropertyAndEquipmentGross' xlink:to='lab_fil_PropertyAndEquipmentGross'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_NetBalance' xlink:label='fil_NetBalance'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetBalance' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net balance</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetBalance' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Net balance</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NetBalance' xlink:to='lab_fil_NetBalance'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_BhangCorporationFormerlyKnownAsBhangChocolateCompanyIncAndJudgmentDetailsAbstract' xlink:label='fil_BhangCorporationFormerlyKnownAsBhangChocolateCompanyIncAndJudgmentDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BhangCorporationFormerlyKnownAsBhangChocolateCompanyIncAndJudgmentDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Bhang Corporation (formerly known as Bhang Chocolate Company, Inc.) and Judgment Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BhangCorporationFormerlyKnownAsBhangChocolateCompanyIncAndJudgmentDetailsAbstract' xlink:to='lab_fil_BhangCorporationFormerlyKnownAsBhangChocolateCompanyIncAndJudgmentDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_BhangCorporationReceivablesAbstract' xlink:label='fil_BhangCorporationReceivablesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BhangCorporationReceivablesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Bhang Corporation Receivables:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BhangCorporationReceivablesAbstract' xlink:to='lab_fil_BhangCorporationReceivablesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock' xlink:label='us-gaap_ScheduleOfOtherAssetsTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Prepaid expense and other assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfOtherAssetsTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ConvertibleNoteReceivable2TextBlock' xlink:label='fil_ConvertibleNoteReceivable2TextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertibleNoteReceivable2TextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Convertible note receivable {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertibleNoteReceivable2TextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Convertible note receivable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertibleNoteReceivable2TextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Policy disclosure is about the Company&apos;s Convertible note receivable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConvertibleNoteReceivable2TextBlock' xlink:to='lab_fil_ConvertibleNoteReceivable2TextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock' xlink:label='us-gaap_ComprehensiveIncomeNoteTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ComprehensiveIncomeNoteTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accumulated other comprehensive income (loss) {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ComprehensiveIncomeNoteTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Accumulated other comprehensive income (loss)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ComprehensiveIncomeNoteTextBlock' xlink:to='lab_us-gaap_ComprehensiveIncomeNoteTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_ConvertibleNoteReceivableTextBlock' xlink:label='fil_ConvertibleNoteReceivableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertibleNoteReceivableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Convertible note receivable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertibleNoteReceivableTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Entire disclosure for convertible note receivable.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConvertibleNoteReceivableTextBlock' xlink:to='lab_fil_ConvertibleNoteReceivableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_BusinessCombinationsAbstract1' xlink:label='fil_BusinessCombinationsAbstract1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BusinessCombinationsAbstract1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Bhang Corporation (formerly known as Bhang Chocolate Company, Inc.) and Judgment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BusinessCombinationsAbstract1' xlink:to='lab_fil_BusinessCombinationsAbstract1'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_CashPaidAtInvestorWebcastDisposition' xlink:label='fil_CashPaidAtInvestorWebcastDisposition'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CashPaidAtInvestorWebcastDisposition' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash paid at Investor Webcast disposition</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CashPaidAtInvestorWebcastDisposition' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Cash paid at Investor Webcast disposition</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CashPaidAtInvestorWebcastDisposition' xlink:to='lab_fil_CashPaidAtInvestorWebcastDisposition'/>
		<link:loc xlink:type='locator' xlink:href='mntr-20170331.xsd#fil_CashAdvancedOnNotesReceivable' xlink:label='fil_CashAdvancedOnNotesReceivable'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CashAdvancedOnNotesReceivable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash advanced on notes receivable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CashAdvancedOnNotesReceivable' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Cash advanced on notes receivable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CashAdvancedOnNotesReceivable' xlink:to='lab_fil_CashAdvancedOnNotesReceivable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromAdvancesForConstruction' xlink:label='us-gaap_ProceedsFromAdvancesForConstruction'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProceedsFromAdvancesForConstruction' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Employee advances {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProceedsFromAdvancesForConstruction' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Employee advances</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ProceedsFromAdvancesForConstruction' xlink:to='lab_us-gaap_ProceedsFromAdvancesForConstruction'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' xlink:label='us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Prepaid expenses and other current assets {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Prepaid expenses and other current assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' xlink:to='lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract' xlink:to='lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract' xlink:label='us-gaap_OtherComprehensiveIncomeLossTaxAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other comprehensive income (loss):</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherComprehensiveIncomeLossTaxAbstract' xlink:to='lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax' xlink:label='us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accumulated other comprehensive income (loss), net of tax</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax' xlink:to='lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract' xlink:label='us-gaap_LiabilitiesCurrentAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesCurrentAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='lab_us-gaap_LiabilitiesCurrentAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property and equipment, net</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentNet' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesReceivableNet' xlink:label='us-gaap_NotesReceivableNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NotesReceivableNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Notes receivable, current portion</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NotesReceivableNet' xlink:to='lab_us-gaap_NotesReceivableNet'/>
	</link:labelLink>
</link:linkbase>
